{"9807":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Stickler syndrome",
  "genes":
  {"2217":{"ontology":"HGNC", "curie":"HGNC:2217", "uri":"HGNC2217"}},
  "title":"COL9A1 Stickler syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1522047600,
  "file":null,
  "dateISO8601":"2018-03-26T00:00:00",
  "entrez_id":"1297",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019354"},
   "OMIM614134":
   {"ontology":"OMIM",
    "curie":"OMIM:614134",
    "uri":"OMIM614134",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_614134"},
   "ORPHA828":
   {"ontology":"ORPHA",
    "curie":"ORPHA:828",
    "uri":"ORPHA828",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_828"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Mar 26, 2018",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1523364140\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"COL9A1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:2217\",\"uri\":\"HGNC2217\"},\"condition\":{\"name\":\"Stickler syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:828\",\"uri\":\"ORPHA828\"},\"MONDO\":{\"curie\":\"MONDO:0019354\",\"uri\":\"MONDO0019354\"},\"OMIM\":{\"curie\":\"OMIM:614134\",\"uri\":\"OMIM614134\"}},\"title\":\"COL9A1 Stickler syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1523363832544\":{\"title\":\"Autosomal recessive Stickler syndrome in two families is caused by mutations in the COL9A1 gene.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2011 Jul 1\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"21421862\"},\"1523363905764\":{\"title\":\"A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.\",\"author\":\"Van Camp G\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Hum Genet\",\"uid\":\"16909383\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"2\":{\"evidence\":{\"publications\":{\"1523364001216\":{\"title\":\"Autosomal recessive Stickler syndrome in two families is caused by mutations in the COL9A1 gene.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2011 Jul 1\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"21421862\"},\"1523364249011\":{\"title\":\"A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.\",\"author\":\"Van Camp G\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Hum Genet\",\"uid\":\"16909383\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1523363862910\":{\"title\":\"Characterization of an abundant COL9A1 transcript in the cochlea with a novel 3\",\"author\":\"Sivakumaran TA\",\"pubdate\":\"2006 Jun\",\"source\":\"J Assoc Res Otolaryngol\",\"uid\":\"16718610\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1523363784484\":{\"title\":\"Type IX collagen is crucial for normal hearing.\",\"author\":\"Asamura K\",\"pubdate\":\"2005\",\"source\":\"Neuroscience\",\"uid\":\"15802199\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"03\/23\/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03\/26\/2018\",\"FinalClassificationNotes\":\"The <i>COL9A1<\/i> gene has been associated with Stickler syndrome in two consanguineous families. The homozygous presumed loss-of-function nonsense variants in this gene segregate with disease in six affected individuals. Splicing, gain-of-function variants in the <i>COL9A1<\/i> gene are associated with autosomal dominant multiple epiphyseal dysplasia (MED), while the mechanism for autosomal recessive Stickler syndrome is thought to be loss of function. This gene-disease association is supported by expression data and by animal models that recapitulate certain phenotypes of the human disease. In summary, <i>COL9A1<\/i> limited in its association with Stickler syndrome.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "10156":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:9024":
   {"ontology":"HGNC", "curie":"HGNC:9024", "uri":"HGNC9024"}},
  "title":"PKP2: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"5318",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530661053\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"PKP2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:9024\",\"uri\":\"HGNC9024\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"PKP2 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530661176682\":{\"title\":\"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.\",\"author\":\"Cerrone M\",\"pubdate\":\"2014 Mar 11\",\"source\":\"Circulation\",\"uid\":\"24352520\"},\"1530661284364\":{\"title\":\"Epicardial Ventricular Tachycardia Ablation in a Patient With Brugada ECG Pattern and Mutation of PKP2 and DSP Genes.\",\"author\":\"Forkmann M\",\"pubdate\":\"2015 Apr\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"25900994\"},\"1530661304856\":{\"title\":\"High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.\",\"author\":\"Hasdemir C\",\"pubdate\":\"2015 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"25998140\"},\"1530661568840\":{\"title\":\"Arrhythmogenic cardiomyopathy and provocable Brugada ECG in a patient caused by missense mutation in plakophilin-2.\",\"author\":\"Peters S\",\"pubdate\":\"2014 May 1\",\"source\":\"Int J Cardiol\",\"uid\":\"24681023\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530661475493\":{\"title\":\"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes.\",\"author\":\"Sato PY\",\"pubdate\":\"2009 Sep 11\",\"source\":\"Circ Res\",\"uid\":\"19661460\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530661505736\":{\"title\":\"Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque.\",\"author\":\"Mertens C\",\"pubdate\":\"1996 Nov\",\"source\":\"J Cell Biol\",\"uid\":\"8922383\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530661691541\":{\"title\":\"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.\",\"author\":\"Cerrone M\",\"pubdate\":\"2014 Mar 11\",\"source\":\"Circulation\",\"uid\":\"24352520\"},\"1530661705685\":{\"title\":\"Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome.\",\"author\":\"Cerrone M\",\"pubdate\":\"2014 Jul\",\"source\":\"Trends Cardiovasc Med\",\"uid\":\"24656989\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.75\",\"NonPatientCells\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530661750267\":{\"title\":\"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes.\",\"author\":\"Sato PY\",\"pubdate\":\"2009 Sep 11\",\"source\":\"Circ Res\",\"uid\":\"19661460\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530661444005\":{\"title\":\"Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency.\",\"author\":\"Cerrone M\",\"pubdate\":\"2012 Sep 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"22764151\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"1.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01\/27\/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "10164":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:17993":
   {"ontology":"HGNC", "curie":"HGNC:17993", "uri":"HGNC17993"}},
  "title":"TRPM4: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"54795",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530666718\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TRPM4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17993\",\"uri\":\"HGNC17993\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"TRPM4 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.25\",\"Tally\":\"2.25\",\"evidence\":{\"publications\":{\"1530666462400\":{\"title\":\"Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings.\",\"author\":\"Duthoit G\",\"pubdate\":\"2012\",\"source\":\"Front Physiol\",\"uid\":\"23293604\"},\"1530666491255\":{\"title\":\"Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel.\",\"author\":\"Liu H\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23382873\"},\"1530666520819\":{\"title\":\"Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome.\",\"author\":\"Gualandi F\",\"pubdate\":\"2017\",\"source\":\"Cardiology\",\"uid\":\"28494446\"},\"1530666668437\":{\"title\":\"Mutational spectrum in the Ca(2+)\u2014activated cation channel gene TRPM4 in patients with cardiac conductance disturbances.\",\"author\":\"Stallmeyer B\",\"pubdate\":\"2012 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"21887725\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530666559902\":{\"title\":\"Increased \\u03b2-adrenergic inotropy in ventricular myocardium from Trpm4-\/- mice.\",\"author\":\"Mathar I\",\"pubdate\":\"2014 Jan 17\",\"source\":\"Circ Res\",\"uid\":\"24226423\"},\"1530666578764\":{\"title\":\"TRPM4 channels in the cardiovascular system.\",\"author\":\"Kruse M\",\"pubdate\":\"2014 Apr\",\"source\":\"Curr Opin Pharmacol\",\"uid\":\"24721656\"},\"1530666703731\":{\"title\":\"Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.\",\"author\":\"Demion M\",\"pubdate\":\"2014\",\"source\":\"PLoS One\",\"uid\":\"25531103\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2.25\",\"ExperimentalEvidenceTotal\":\"0.5\",\"EvidencePointsTotal\":\"2.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/09\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8257":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:7590":
   {"ontology":"HGNC", "curie":"HGNC:7590", "uri":"HGNC7590"}},
  "title":
  "MYLK : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MYLK\",\"Hgnc\":\"7590\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"600922\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"},{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"},{\"title\":\"Performant Mutation Identification Using Targeted Next-Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes.\",\"author\":\"Proost D\",\"pubdate\":\"2015 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"25907466\"}],\"notes\":{\"note\":\"PMID 21055718: Panel sequencing of a few candidate genes in 94 probands from families with thoracic aortic aneurysm and aortic dissection (TAAD). 1 variant in MYLK absent in ethnically matched controls (+ 4 others) p.S1759P. Also identified a p.R1480X in an unrelated proband. Additional 3 variants in 3 other probands: p.A1754T,  p.V1213M p.E1399K not present in ethnically-matched controls but no family data . Points =1 due to lack of gene impact evidence (ignored the latter three missense variants). \\r\\nPMID 26188975:  Found a mutation (p.P1759S) reported earlier in 1 proband; segregated with disease in her family. Points= 0.5\\r\\nPMID 25907466: Identified one proband with p.R1487* . Points=0.5\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"},{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"}],\"notes\":{\"note\":\"PMID 21055718: Panel sequencing of a few candidate genes in 94 probands from families with TAAD\\r\\n1 variant in MYLK absent in ethnically matched controls (+ 4 others) p.S1759P segregated with disease in family (3 probands).\\r\\nFurther sequencing of MYLK in 99 probands with additional TAAD \\u2013 found another variant \\r\\n(p.R1480X) that segregated with disease in family LOD score 1.2 (increased to 1.8 with addition of family members who had sudden death)  Points 3\\r\\nPMID 26188975: weak segregation data. Less than 4 convincing segregations. 1 point.\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Signaling through myosin light chain kinase in smooth muscles.\",\"author\":\"Gao N\",\"pubdate\":\"2013 Mar 15\",\"source\":\"J Biol Chem\",\"uid\":\"23362260\"},{\"title\":\"Notch transcriptional control of vascular smooth muscle regulatory gene expression and function.\",\"author\":\"Basu S\",\"pubdate\":\"2013 Apr 19\",\"source\":\"J Biol Chem\",\"uid\":\"23482558\"},{\"title\":\"Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.\",\"author\":\"Basu S\",\"pubdate\":\"2016 Feb 5\",\"source\":\"J Biol Chem\",\"uid\":\"26703474\"}],\"notes\":{\"note\":\"PMID 23362260: A 50% decrease in MLCK (=MYLK) in aortic smooth muscle resulted in 40% inhibition of myosin regulatory light chain phosphorylation and aorta contractile responses, whereas a 90% decrease profoundly inhibited both responses. \\r\\nPMID 23482558: Demonstrated that NOTCH1 induced MYLK expression. Knocked out NOTCH1 signaling in vascular smooth muscle cells (vSMC) in mice. This reduced MYLK expression and activity. Supported by report of NOTCH1-responsive element in MYLK promoter\\r\\nPMID 26703474 showed co-immunoprecipitation of MYLK promoter and JAGGED1 ligand & also MYLK promoter with NOTCH1-enhanced myocardin\/SRF complex, & demonstrated each of these enhanced MYLK expression.\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"}],\"notes\":{\"note\":\"Patient cells: \\r\\nAuthors transfected COS7 cells with mutations p.S1759P and p.A1754T. Demonstrated significantly reduced (p.1754T) ) or abolished (p.S1759P) calmodulin binding in transfected cells & reduced kinase activity.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"}],\"notes\":{\"note\":\"Authors generated a tamoxifen-induced, SMC specific knockout of MYLK & examined aortas after 13 days.\\r\\nIncreased proteoglycan deposition in aortic media\\r\\nIncreased collagen deposition in adventitia\\r\\nIncreased expression of MMP2\\r\\nNo aortic phenotype (mice with SMC \\u2013 specific k\/o usually die due to low BP, reduced gut mobility, airway constriction and urinary dysfunction)  - note low BP similar to ACTA2 k\/o effects\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"11\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"04\/06\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"04\/06\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"12\/18\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. \\r\\nExperts added 1 point, originally moderate classification. \"}}",
  "date":1482048000,
  "file":null,
  "dateISO8601":"2016-12-18T00:00:00",
  "entrez_id":"4638",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM600922":
   {"ontology":"OMIM",
    "curie":"OMIM:600922",
    "uri":"OMIM600922",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_600922"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3978":{"label":"Strong"}},
  "dateFormated":"Dec 18, 2016",
  "scoreJsonSerializedSop5":""},
 "8692":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:26881":
   {"ontology":"HGNC", "curie":"HGNC:26881", "uri":"HGNC26881"}},
  "title":"GEN1: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"GEN1\",\"Hgnc\":\"26881\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"01\/11\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"01\/11\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1484121600,
  "file":null,
  "dateISO8601":"2017-01-11T00:00:00",
  "entrez_id":"348654",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Jan 11, 2017",
  "scoreJsonSerializedSop5":""},
 "5661":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 2",
  "genes":
  {"12601":
   {"ontology":"HGNC", "curie":"HGNC:12601", "uri":"HGNC12601"}},
  "title":"USH2A Usher syndrome type 2",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"USH2A\",\"Hgnc\":\"12601\",\"OrphaNet\":\"ORPHA231178\",\"Disease\":\"Usher syndrome type 2\",\"Omim\":\"276901\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.\",\"author\":\"Eudy JD\",\"pubdate\":\"1998 Jun 12\",\"source\":\"Science\",\"uid\":\"9624053\"},{\"title\":\"Molecular genetics of the Usher syndrome in Lebanon: identification of 11 novel protein truncating mutations by whole exome sequencing.\",\"author\":\"Reddy R\",\"pubdate\":\"2014 Sep 11\",\"source\":\"PLoS One\",\"uid\":\"25211151\"},{\"title\":\"Functional analysis of splicing mutations in MYO7A and USH2A genes.\",\"author\":\"Jaijo T\",\"pubdate\":\"2011 Mar\",\"source\":\"Clin Genet\",\"uid\":\"20497194\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"14.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"9.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.\",\"author\":\"Eudy JD\",\"pubdate\":\"1998 Jun 12\",\"source\":\"Science\",\"uid\":\"9624053\"},{\"title\":\"Molecular genetics of the Usher syndrome in Lebanon: identification of 11 novel protein truncating mutations by whole exome sequencing.\",\"author\":\"Reddy R\",\"pubdate\":\"2014 Sep 11\",\"source\":\"PLoS One\",\"uid\":\"25211151\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells.\",\"author\":\"Adato A\",\"pubdate\":\"2005 Dec 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16301217\"},{\"title\":\"Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations.\",\"author\":\"Garcia-Garcia G\",\"pubdate\":\"2011 Oct 17\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"22004887\"},{\"title\":\"Functional analysis of splicing mutations in MYO7A and USH2A genes.\",\"author\":\"Jaijo T\",\"pubdate\":\"2011 Mar\",\"source\":\"Clin Genet\",\"uid\":\"20497194\"},{\"title\":\"Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.\",\"author\":\"Liu X\",\"pubdate\":\"2007 Mar 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17360538\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"0\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Cell transplantation to arrest early changes in an ush2a animal model.\",\"author\":\"Lu B\",\"pubdate\":\"2010 Apr\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"19959642\"},{\"title\":\"Individual USH2 proteins make distinct contributions to the ankle link complex during development of the mouse cochlear stereociliary bundle.\",\"author\":\"Zou J\",\"pubdate\":\"2015 Dec 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"26401052\"},{\"title\":\"Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.\",\"author\":\"Liu X\",\"pubdate\":\"2007 Mar 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17360538\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09\/22\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1487145600,
  "file":null,
  "dateISO8601":"2017-02-15T00:00:00",
  "entrez_id":"7399",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016484"},
   "OMIM276901":
   {"ontology":"OMIM",
    "curie":"OMIM:276901",
    "uri":"OMIM276901",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_276901"},
   "ORPHA231178":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231178",
    "uri":"ORPHA231178",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231178"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2017",
  "scoreJsonSerializedSop5":""},
 "8525":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:6954":
   {"ontology":"HGNC", "curie":"HGNC:6954", "uri":"HGNC6954"}},
  "title":"MCPH1: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MCPH1\",\"Hgnc\":\"6954\",\"OrphaNet\":\"ORPHA213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"01\/11\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"01\/11\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1484121600,
  "file":null,
  "dateISO8601":"2017-01-11T00:00:00",
  "entrez_id":"79648",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Jan 11, 2017",
  "scoreJsonSerializedSop5":""},
 "8251":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:3603":
   {"ontology":"HGNC", "curie":"HGNC:3603", "uri":"HGNC3603"}},
  "title":
  "FBN1 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"FBN1\",\"Hgnc\":\"3603\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"134797\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.\",\"author\":\"Milewicz DM\",\"pubdate\":\"1996 Dec 1\",\"source\":\"Circulation\",\"uid\":\"8941093\"},{\"title\":\"TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.\",\"author\":\"Katzke S\",\"pubdate\":\"2002 Sep\",\"source\":\"Hum Mutat\",\"uid\":\"12203992\"},{\"title\":\"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.\",\"author\":\"Francke U\",\"pubdate\":\"1995 Jun\",\"source\":\"Am J Hum Genet\",\"uid\":\"7762551\"}],\"notes\":{\"note\":\"PMID 8941093: Two novel FBN1 alterations were identified in individuals with Thoracic Aortic Aneurysms (TAAs) involving the ascending thoracic aorta. Dermal fibroblasts from one of the affected individual were used to study the effect of the missense mutation D1155N on fibrillin-1 cellular processing. The mutation decreased the amount of fibrillin-1 deposited into the pericellular matrix. Points 1.5 + 0.5\\r\\nPMID 12203992: 19 probands with syndromic Aortic dissection\/aneurysm\/dilation. One with possible isolated TAA with other features not satisfying Ghent nosology for Marfan's syndrome . The others manifest variable degrees of Marfan's. Points 1\\r\\nPMID 7762551: A Gly1127Ser substitution was present in 9 of 10 affected family members and in 1 young unaffected member but was not found in other unaffected members. Functional studies show reduced FBN deposition in ECM in cultured fibroblasts. Points 1.5\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.\",\"author\":\"Francke U\",\"pubdate\":\"1995 Jun\",\"source\":\"Am J Hum Genet\",\"uid\":\"7762551\"}],\"notes\":{\"note\":\"10 individuals in two generations are affected with abnormalities of\\r\\nthe ascending aorta, ranging from mild root dilatation\\r\\nto aortic aneurysm or dissection. See Figure 5 for pedigree. \"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.\",\"author\":\"Francke U\",\"pubdate\":\"1995 Jun\",\"source\":\"Am J Hum Genet\",\"uid\":\"7762551\"},{\"title\":\"Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.\",\"author\":\"Milewicz DM\",\"pubdate\":\"1996 Dec 1\",\"source\":\"Circulation\",\"uid\":\"8941093\"}],\"notes\":{\"note\":\"PMID 7762551: Functional studies show reduced FBN deposition in extra cellular matrix in cultured fibroblasts from a carrier with Gly1127Ser\\r\\nPMID 8941093 The D1155N mutation decreased the amount of fibrillin-1 deposited into the pericellular matrix\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.\",\"author\":\"Pereira L\",\"pubdate\":\"1997 Oct\",\"source\":\"Nat Genet\",\"uid\":\"9326947\"},{\"title\":\"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.\",\"author\":\"Neptune ER\",\"pubdate\":\"2003 Mar\",\"source\":\"Nat Genet\",\"uid\":\"12598898\"},{\"title\":\"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.\",\"author\":\"Judge DP\",\"pubdate\":\"2004 Jul\",\"source\":\"J Clin Invest\",\"uid\":\"15254584\"}],\"notes\":{\"note\":\"PMID: 9326947\\r\\nTargeted partial deletion of mouse FBN1.\\r\\nAlthough homozygous mutants did not display skeletal abnormalities , all animals \\r\\ndied suddenly of cardiovascular complications. All showed vascular compromise of some sort\\r\\nIncluding focal fragmentation of elastic fibers, thinning of wall of proximal ascending aorta etc.\\r\\nIt did not seem to affect elastic matrix assembly.\\r\\nPMID 12598898 , using the above mice model, observed developmental impairment of distal \\r\\nalveolar septation. By 6 months of age, Fbn1mgR\/mgR mice developed marked airspace dilatation associated with destructive changes, peribronchiolar inflammation and greater expression of matrix metalloproteases , recapitulating the pathologic findings of human emphysema.\\r\\nPMID 15254584: Mice heterozygous for a  comparable missense mutation (C1039G) revealed impaired microfibrillar deposition, skeletal deformity, and progressive deterioration of aortic wall architecture, comparable to  characteristics of the human phenotype. Introduction of a WT FBN1 transgene on a heterozygous  C1039G background rescued aortic phenotype.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01\/04\/2017\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"01\/04\/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01\/23\/2017\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
  "date":1485158400,
  "file":null,
  "dateISO8601":"2017-01-23T00:00:00",
  "entrez_id":"2200",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM134797":
   {"ontology":"OMIM",
    "curie":"OMIM:134797",
    "uri":"OMIM134797",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_134797"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jan 23, 2017",
  "scoreJsonSerializedSop5":""},
 "9867":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"29805":
   {"ontology":"HGNC", "curie":"HGNC:29805", "uri":"HGNC29805"}},
  "title":"NFKBIZ: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"NFKBIZ\",\"Hgnc\":\"29805\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"0.1\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/10\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"07\/10\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1499670000,
  "file":null,
  "dateISO8601":"2017-07-10T00:00:00",
  "entrez_id":"64332",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Jul 10, 2017",
  "scoreJsonSerializedSop5":""},
 "10157":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:17679":
   {"ontology":"HGNC", "curie":"HGNC:17679", "uri":"HGNC17679"}},
  "title":"RANGRF: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"29098",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530662466\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"RANGRF\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17679\",\"uri\":\"HGNC17679\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"RANGRF Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530662000378\":{\"title\":\"MOG1: a new susceptibility gene for Brugada syndrome.\",\"author\":\"Kattygnarath D\",\"pubdate\":\"2011 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"21447824\"},\"1530662019058\":{\"title\":\"Brugada syndrome and p.E61X_RANGRF.\",\"author\":\"Campuzano O\",\"pubdate\":\"2014\",\"source\":\"Cardiol J\",\"uid\":\"24142675\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530662409648\":{\"title\":\"Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5.\",\"author\":\"Wu L\",\"pubdate\":\"2008 Mar 14\",\"source\":\"J Biol Chem\",\"uid\":\"18184654\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.25\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662131555\":{\"title\":\"MOG1: a new susceptibility gene for Brugada syndrome.\",\"author\":\"Kattygnarath D\",\"pubdate\":\"2011 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"21447824\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662090646\":{\"title\":\"A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias.\",\"author\":\"Olesen MS\",\"pubdate\":\"2011 Jul-Aug\",\"source\":\"Can J Cardiol\",\"uid\":\"21621375\"},\"1530662423156\":{\"title\":\"Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5.\",\"author\":\"Wu L\",\"pubdate\":\"2008 Mar 14\",\"source\":\"J Biol Chem\",\"uid\":\"18184654\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530662337026\":{\"title\":\"MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome.\",\"author\":\"Chakrabarti S\",\"pubdate\":\"2013 Apr\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"23420830\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662097285\":{\"title\":\"A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias.\",\"author\":\"Olesen MS\",\"pubdate\":\"2011 Jul-Aug\",\"source\":\"Can J Cardiol\",\"uid\":\"21621375\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530662110517\":{\"title\":\"Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm.\",\"author\":\"Zhou J\",\"pubdate\":\"2016 Feb 23\",\"source\":\"Sci Rep\",\"uid\":\"26903377\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"2.25\",\"EvidencePointsTotal\":\"2.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01\/12\/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8261":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:3808":
   {"ontology":"HGNC", "curie":"HGNC:3808", "uri":"HGNC3808"}},
  "title":
  "FOXE3 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"FOXE3\",\"Hgnc\":\"3808\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601094\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"FOXE3 c.457G>C (p.Asp153His), segregated with aortic disease in TAA337. This variant is present once in 13,000 chromosomes in the ESP database and disrupts an evolutionarily conserved amino acid. Proband from this family is considered.\\r\\n\\r\\nExome and Sanger sequencing of 564 unrelated FTAAD probands identified 7 additional FOXE3 rare variants predicted to disrupt the protein: p.Pro112Ser, p.Gly137Asp, p.Asp156Asn, p.Arg164Ser, p.Gly196Ala, p.Pro202Leu, and p.Ser300Gly. Variant p.Gly137Asp was identified in affected members of a small family with aortic root dilatation ; no additional samples were available from the other families.  Thus considering only these two probands with a total point of 2.\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"FOXE3 c.457G>C (p.Asp153His), segregated with aortic disease in TAA337 . Segregation of the FOXE3 variant with aortic disease in this family revealed a lod score of 3.00. \\r\\n\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"Expression:\\r\\nFoxe3 expression induced in aortas of WT mice stressed with TAC 1 points.\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"5.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"Model System:\\r\\n1) Morpholino knock-down in Zebrafish resulting in Disrupted aortic arches. Clear effect on aortic development; direct parallel with aortic dissection unclear. \\r\\n2) Rescue in engineered equivalent;\\r\\nSignificant rescue of phenotype with wild-type copy; only partial rescue with patient variant.Not technically a cellular phenotype, but clearly phenotype in model organism which is relevant to disease - perhaps strong enough to note but not earning \\\"maximum\\\" points for rescue. \\r\\n3) Mouse KO model with  reduced smooth muscle cell number and density; on further stressing with transverse aortic constriction (TAC), evidence of aortic rupture, intramural haematoma. Model shows clear parallel phenotype - but also suggests knockout may not by itself be sufficient for phenotype.\\r\\n4 points for model system, 1 point for rescue.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"7\",\"GeneticEvidencePointsTotal\":\"7\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"03\/09\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"06\/15\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\n\\r\\nRecent gene, no strong replication of the data so far. Additional data to confirm clinically relevant HTAAD required  - 1 point subtracted\"}}",
  "date":1465974000,
  "file":null,
  "dateISO8601":"2016-06-15T00:00:00",
  "entrez_id":"2301",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM601094":
   {"ontology":"OMIM",
    "curie":"OMIM:601094",
    "uri":"OMIM601094",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601094"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3976":{"label":"Moderate"}},
  "dateFormated":"Jun 15, 2016",
  "scoreJsonSerializedSop5":""},
 "4843":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Spondyloepiphyseal dysplasia (Stanescu type)",
  "genes":
  {"HGNC:2200":
   {"ontology":"HGNC", "curie":"HGNC:2200", "uri":"HGNC2200"}},
  "title":"COL2A1 Spondyloepiphyseal dysplasia Stanescu type",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"COL2A1\",\"Hgnc\":\"2200\",\"OrphaNet\":\"N\/A\",\"Disease\":\"Spondyloepiphyseal dysplasia (Stanescu type)\",\"Omim\":\"616583\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.\",\"author\":\"Jurgens J\",\"pubdate\":\"2015 Oct\",\"source\":\"Hum Mutat\",\"uid\":\"26183434\"},{\"title\":\"Pathogenenic variant in the COL2A1 gene is associated with Spondyloepiphyseal dysplasia type Stanescu.\",\"author\":\"Hammarsj\\u00f6 A\",\"pubdate\":\"2016 Jan\",\"source\":\"Am J Med Genet A\",\"uid\":\"26420734\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.\",\"author\":\"Jurgens J\",\"pubdate\":\"2015 Oct\",\"source\":\"Hum Mutat\",\"uid\":\"26183434\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia.\",\"author\":\"Chan D\",\"pubdate\":\"1993 Jul 15\",\"source\":\"J Biol Chem\",\"uid\":\"8325895\"},{\"title\":\"Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia.\",\"author\":\"Vandenberg P\",\"pubdate\":\"1991 Sep 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1881905\"},{\"title\":\"Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.\",\"author\":\"Garofalo S\",\"pubdate\":\"1991 Nov 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1946380\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia.\",\"author\":\"Vandenberg P\",\"pubdate\":\"1991 Sep 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1881905\"},{\"title\":\"Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.\",\"author\":\"Garofalo S\",\"pubdate\":\"1991 Nov 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1946380\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"3\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"9\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"05\/25\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12\/01\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1480579200,
  "file":null,
  "dateISO8601":"2016-12-01T00:00:00",
  "entrez_id":"1280",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0014701"},
   "OMIM616583":
   {"ontology":"OMIM",
    "curie":"OMIM:616583",
    "uri":"OMIM616583",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_616583"},
   "ORPHA":
   {"ontology":"ORPHA",
    "curie":"ORPHA:",
    "uri":"ORPHA",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_"}},
  "scores":{"3976":{"label":"Moderate"}},
  "dateFormated":"Dec 01, 2016",
  "scoreJsonSerializedSop5":""},
 "8259":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:9414":
   {"ontology":"HGNC", "curie":"HGNC:9414", "uri":"HGNC9414"}},
  "title":
  "PRKG1 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"PRKG1\",\"Hgnc\":\"9414\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"176894\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"7.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"},{\"title\":\"PRKG1 and genetic diagnosis of early-onset thoracic aortic disease.\",\"author\":\"Gago-D\\u00edaz M\",\"pubdate\":\"2016 Sep\",\"source\":\"Eur J Clin Invest\",\"uid\":\"27442293\"}],\"notes\":{\"note\":\" PMID 23910461: Exome sequencing of distant relatives affected by thoracic aortic disease and subsequent Sanger sequencing of additional probands with familial thoracic aortic disease identified the same rare variant,  c.530G>A (p.Arg177Gln), in four families. This mutation segregated with aortic disease in these families with a combined two-point LOD score of 7.88. Also the GOF property of this mutation was demonstrated by functional assays. Proband  score=4 *1.5=6\\r\\nPMID 27442293: One proband with the Arg177Gln mutation ,segregating in 7 affected and 5 unaffected members. Points=1 *1.5 \"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"}],\"notes\":{\"note\":\"PMID 23910461: PRKG1 c.530G>A (p.Arg177Gln) segregated with aortic disease in these families with a combined two-point LOD score of 7.88. \"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"}],\"notes\":{\"note\":\"Biochemical function:\\r\\nRegulation of control of VSMC relaxation via phosphorylation of myosin regulatory light chain. Similar to disease mechanisms from MYLK, MYH11, ACTA2 mutations known to cause disease. Points=0.5\\r\\nProtein Interaction:\\r\\nPhysical interaction with myosin (phosphorylation via regulation of phosphatase). Regulation of smooth muscle contractile apparatus similar to MYLK, a gene strongly associated with thoracic aortic aneurysm (TAA) and aortic dissection. Points=0.5\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"}],\"notes\":{\"note\":\"Patient cells:\\r\\nReduced phosphorylated myosin regulatory light chain in patient fibroblasts compared with controls. Points 1\\r\\nNon patient cells:\\r\\nTransfection of HEK cells with mutations in PRKG1  increases cGMP-controlled kinase activity suggesting gain of function property. Points=1\"}}},\"ModelsRescue\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Defective smooth muscle regulation in cGMP kinase I-deficient mice.\",\"author\":\"Pfeifer A\",\"pubdate\":\"1998 Jun 1\",\"source\":\"EMBO J\",\"uid\":\"9606187\"}],\"notes\":{\"note\":\"PRKG1-k\/o mice: PRKG1 k\/o showed reduced responsiveness of aortic rings to acetylcholine \\u2013 reduced relaxation\\r\\nPRKG1 k\/o were hypertensive.\\r\\nMouse model: 1pts (abnormalities of aortic function but no TAA phenotype)\\r\\nClear abnormal aortic phenotype but not directly mimicking human disease - 1 point.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"07\/12\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"STRONG\",\"CuratorClassificationDate\":\"07\/12\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. \\r\\nOne point subtracted for weak mouse model phenotype (does not recapitulate gain of function) .\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"5592",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM176894":
   {"ontology":"OMIM",
    "curie":"OMIM:176894",
    "uri":"OMIM176894",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_176894"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3978":{"label":"Strong"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "8252":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:7569":
   {"ontology":"HGNC", "curie":"HGNC:7569", "uri":"HGNC7569"}},
  "title":
  "MYH11 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MYH11\",\"Hgnc\":\"7569\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"160745\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.\",\"author\":\"Pannu H\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"17666408\"},{\"title\":\"Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF\\u03b2 signaling in FTAAD.\",\"author\":\"Renard M\",\"pubdate\":\"2013 May 10\",\"source\":\"Int J Cardiol\",\"uid\":\"21937134\"},{\"title\":\"Incomplete segregation of MYH11 variants with thoracic aortic aneurysms and dissections and patent ductus arteriosus.\",\"author\":\"Harakalova M\",\"pubdate\":\"2013 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"22968129\"},{\"title\":\"TGF\\u03b2RIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor \\u03b22 signal transduction.\",\"author\":\"Bee KJ\",\"pubdate\":\"2012 Dec\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"23099432\"},{\"title\":\"A deleterious MYH11 mutation causing familial thoracic aortic dissection.\",\"author\":\"Takeda N\",\"pubdate\":\"2015\",\"source\":\"Hum Genome Var\",\"uid\":\"27081537\"},{\"title\":\"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus.\",\"author\":\"Zhu L\",\"pubdate\":\"2006 Mar\",\"source\":\"Nat Genet\",\"uid\":\"16444274\"}],\"notes\":{\"note\":\"PMID 16444274: Systematic mutation screening identified two cis heterozygous mutations affecting in the French kindred\\r\\nIVS32+1GT (splice-donor site of intron 32), p.R1758Q(exon 37) Both mutations were identified in all subjects carrying the disease haplotype, but neither was found in 340 normal chromosomes. Also absent in ExAC. Probands 1 . Points=1\\r\\n\\r\\n17666408 Variants L1264P and R1275L in coiled coiled domain coseggregated with Thoracic aortic aneurysm and aortic dissection (TAAD) in 3 Generation family. Structural analysis suggested that the mutations found in the TAAD\/PDA families are predicted to be deleterious to protein function. Probands 1, Points 0.5 \\r\\n\\r\\nPMID 21937134:  In 1 family with TAAD associated with PDA, a causal aberration in MYH11 was found in one family : IVS32+1G  mutation in intron 32. This variant was previously reported by PMID 16444274 .ExAC Allele Frequency:0.02% 1 proband, Points=0.5 \\r\\n\\r\\nPMID 22968129: Two different novel heterozygote MYH11 variants were detected\\r\\nin the probands two large Dutch families with TAAD\/PDA. However, these variants incomplete segregation with the TAAD\/PDA in 3 out of 11 cases in family 1 and in 2 out of 6 cases of family 2. One missense and one inframe deletion was identified. p.K78E was absent in ExAC.No other evidence in support of pathogenicity of variant.However this variant was also identified in a Japanese pedigree (PMID:26056961) segregating TAAD. Number of Probands: 1, Points=0.5 \\r\\n\\r\\nPMID 23099432: MYH11 mutations were identified in three unrelated probands. No other functional tests supporting variant pathogenicity.\\r\\nNumber of probands from this study: 1 (p.R1590Q ), Points=0.5\\r\\n\\r\\nPMID 26056961 : Heterozygous in frame deletion p.K1256del was identified in affected members of two Japanese pedigrees. Cosegregation was shown in one pedigree. One pediatric case with this variant had  TAA + PDA but the rest were non syndromic. <0.0001% in ExAC Variant is in a conserved residue of a functional (rod) domain.# of probands from this study : 1 points=0.5\\r\\n\\r\\nPMID 27081537: Familial case of non-syndromic TAAD with a MYH11 L1264P mutation, \\r\\nin which PDA was not observed. (Authors performed genetic analyses of mutations of the TAAD related genes including FBN1, TGFBR1, TGFBR2, SMAD3, TGFB2, ACTA2 and MYH11)\\r\\nCo-segregation was shown in a 17 member three generation  pedigree.\\r\\nThis variant was recurrent ( also observed in PMID 17666408)\\r\\nAbsent in ExAC. Variant is in a conserved residue of a functional domain.\\r\\n# of probands= 1, Points=1\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mapping of familial thoracic aortic aneurysm\/dissection with patent ductus arteriosus to 16p12.2-p13.13.\",\"author\":\"Khau Van Kien P\",\"pubdate\":\"2005 Jul 12\",\"source\":\"Circulation\",\"uid\":\"15998682\"},{\"title\":\"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.\",\"author\":\"Pannu H\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"17666408\"},{\"title\":\"Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF\\u03b2 signaling in FTAAD.\",\"author\":\"Renard M\",\"pubdate\":\"2013 May 10\",\"source\":\"Int J Cardiol\",\"uid\":\"21937134\"},{\"title\":\"TGF\\u03b2RIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor \\u03b22 signal transduction.\",\"author\":\"Bee KJ\",\"pubdate\":\"2012 Dec\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"23099432\"}],\"notes\":{\"note\":\"15998682: 3-generation French family with TAAD, patent ductus arteriosus (PDA), or both. Considering only the 7 TAAD cases, max LOD score of 2.73 was obtained at  \\u03b8=0, at 16p12.2\\u2013p13.3 region. If the 5 PDA cases are considered affected, stronger values were observed at this region, with a maximum LOD score of 3. Points 4\\r\\n17666408: segregation data from family TAA027 was included in the curation. Included but there was PDA in two individuals.  Points=1\\r\\n\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus.\",\"author\":\"Zhu L\",\"pubdate\":\"2006 Mar\",\"source\":\"Nat Genet\",\"uid\":\"16444274\"}],\"notes\":{\"note\":\"Expression: PMID 16444274: Immunoblotting of  proteins extracted from pathological aorta confirmed presence of similar amounts of wild type and mutant SM-MHC. Points 0.5\\r\\n \\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus.\",\"author\":\"Zhu L\",\"pubdate\":\"2006 Mar\",\"source\":\"Nat Genet\",\"uid\":\"16444274\"},{\"title\":\"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.\",\"author\":\"Pannu H\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"17666408\"}],\"notes\":{\"note\":\"Patient cells.\\r\\nPMID 16444274: Orcein staining of elastic fibers from probands harboring MYH11 mutations shows decrease in number and rupture of elastic fibers. Actin labelling and alcian staining revealed abnormalities of SMCs and  deposition of mucopolysaccharides where SMCs were lost.\\r\\nPMID 17666408 Histopathological analysis of aortic sections from two individuals with MYH11 mutations revealed SMC disarray and focal hyperplasia of SMCs in the aortic media. \"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2012 May 25\",\"source\":\"Circ Res\",\"uid\":\"22511748\"},{\"title\":\"Myh11(R247C\/R247C) mutations increase thoracic aorta vulnerability to intramural damage despite a general biomechanical adaptivity.\",\"author\":\"Bellini C\",\"pubdate\":\"2015 Jan 2\",\"source\":\"J Biomech\",\"uid\":\"25433566\"}],\"notes\":{\"note\":\"Mild phenotypes\\r\\nPMID 22511748 Myh11 R247C\/R247C knock in mice exhibited normal growth, reproduction, and aortic histology but decreased aortic contraction. The decrease in aortic contractility was not associated with aortic pathology in these mice and suggests that decreased aortic contractility alone may not be sufficient to cause thoracic aortic disease.\\r\\n25433566: The mutant aortas were generally  normal , under  hypertensive hemodynamics, there was intramural delaminations or premature deaths in 20% of R247C knock-in mice.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"04\/04\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"04\/04\/2016\",\"CuratorClassificationNotes\":\"Considering only isolated TAAD. \",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"07\/03\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nAssociation with TAA is  strong if patients with Patent Ductus Arteriosus and TAAD are considered together. \"}}",
  "date":1467529200,
  "file":null,
  "dateISO8601":"2016-07-03T00:00:00",
  "entrez_id":"4629",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM160745":
   {"ontology":"OMIM",
    "curie":"OMIM:160745",
    "uri":"OMIM160745",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_160745"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jul 03, 2016",
  "scoreJsonSerializedSop5":""},
 "3206":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Diamond-Blackfan anemia",
  "genes":
  {"HGNC:10411":
   {"ontology":"HGNC", "curie":"HGNC:10411", "uri":"HGNC10411"}},
  "title":"RPS24  Diamond-Blackfan anemia",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"RPS24\",\"Hgnc\":\"10411\",\"OrphaNet\":\"ORPHA124\",\"Disease\":\"Diamond-Blackfan anemia\",\"Omim\":\"610629\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.\",\"author\":\"Quarello P\",\"pubdate\":\"2010 Feb\",\"source\":\"Haematologica\",\"uid\":\"19773262\"},{\"title\":\"Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia.\",\"author\":\"Landowski M\",\"pubdate\":\"2013 Nov\",\"source\":\"Hum Genet\",\"uid\":\"23812780\"},{\"title\":\"Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.\",\"author\":\"Smetanina NS\",\"pubdate\":\"2015 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"25946618\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.\",\"author\":\"Gazda HT\",\"pubdate\":\"2006 Dec\",\"source\":\"Am J Hum Genet\",\"uid\":\"17186470\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder.\",\"author\":\"Choesmel V\",\"pubdate\":\"2008 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"18230666\"},{\"title\":\"A census of human soluble protein complexes.\",\"author\":\"Havugimana PC\",\"pubdate\":\"2012 Aug 31\",\"source\":\"Cell\",\"uid\":\"22939629\"},{\"title\":\"Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.\",\"author\":\"Gazda HT\",\"pubdate\":\"2006 Dec\",\"source\":\"Am J Hum Genet\",\"uid\":\"17186470\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder.\",\"author\":\"Choesmel V\",\"pubdate\":\"2008 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"18230666\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"10.5\",\"GeneticEvidencePointsTotal\":\"10.5\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07\/04\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01\/17\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1484812800,
  "file":null,
  "dateISO8601":"2017-01-19T00:00:00",
  "entrez_id":"6229",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015253"},
   "OMIM610629":
   {"ontology":"OMIM",
    "curie":"OMIM:610629",
    "uri":"OMIM610629",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_610629"},
   "ORPHA124":
   {"ontology":"ORPHA",
    "curie":"ORPHA:124",
    "uri":"ORPHA124",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_124"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jan 19, 2017",
  "scoreJsonSerializedSop5":""},
 "8253":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:6769":
   {"ontology":"HGNC", "curie":"HGNC:6769", "uri":"HGNC6769"}},
  "title":
  "SMAD3 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"SMAD3\",\"Hgnc\":\"6769\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"603109\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"}],\"notes\":{\"note\":\"A frameshift mutation (p.N218fs) introducing a premature stop codon was present in all individuals with vascular disease in a 4 generation family, including Thoracic aortic aneurysm and dissection (TAAD), Intracranial aneurysms, Abdominal aortic aneurysm (AAA), and bilateral iliac aneurysms. The SMAD3 mutation segregated with vascular diseases in the family with a LOD score of 2.52 and was absent from approximately 2300 control exomes.  Total points .5\\r\\n\\r\\nSMAD3 exons and flanking introns were amplified and sequenced as a candidate gene for FTAAD using DNA from 181 unrelated FTAAD probands. Sequencing identified 3 additional variants in four families of European descent: p.R279K (c.836G>A, exon 6) in families TAA071 and TAA072, p.E239K (c.715G>A, exon 6) in family TAA365, and p.A112V (c.235C>T, exon 2) in TAA115.  Total points in absence of functional studies=1.5\"}}},\"ProbandWithLOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Multiple aneurysms in a patient with aneurysms-osteoarthritis syndrome.\",\"author\":\"Martens T\",\"pubdate\":\"2013 Jan\",\"source\":\"Ann Thorac Surg\",\"uid\":\"23272854\"}],\"notes\":{\"note\":\"PMID 23272854: Identified in a single affected individual with no reported family history; variant de novo\\r\\n\"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"}],\"notes\":{\"note\":\"Linkage analysis using 250K SNP arrays in family 1. We obtained a significant multipoint log^sub 10^ odds (LOD) score of 3.6 on chromosome 15q. Haplotype analysis confirmed that all 12 individuals with arterial aneurysms and 10 individuals with skeletal and\/or cutaneous anomalies (not included in the GWLA) shared the disease-associated haplotype. Note that the linkage analysis was done with 12 individuals with arterial aneurysms and hence included and assigned 4 points*-\\r\\n\\r\\n21778426: A novel frame shift mutation, p. N218fs (c.652delA), was identified in the SMAD3 gene and segregated with the vascular diseases in this family with a LOD score of 2.52. However this is not specific to TAAD. Assigned 2 points\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS.\",\"author\":\"Tan CK\",\"pubdate\":\"2013 Jun 19\",\"source\":\"J Am Heart Assoc\",\"uid\":\"23782924\"},{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"}],\"notes\":{\"note\":\"Biochemical function: PMID 23782924: in vitro study showed that SMAD3 regulates the transcriptional activity of the iNOS promoter via C\/EBP\\u03b2 (9134219);  in vivo ChIP using anti\\u2010C\/EBP\\u03b2 antibodies on primary vascular cells isolated from untreated S3KO (SMAD3-knockout mice) and WT aorta revealed increased association of C\/EBP\\u03b2 with a putative C\/EBP binding site spanning \\u2212515 to \\u2212318 bp within the iNOS promoter in S3KO cells; Consistent with phenotype: Lack of Smad3p causes aberrant upregulation of inducible nitric oxide synthase (iNOS)\\u2013derived nitric oxide production and activation of elastolytic matrix metalloproteinases 2 and 9. Administration of clodronate\\u2010liposomes and iNOS inhibitor completely abrogated these aortic conditions\\r\\nExpression\\r\\nPMID 1217753: SMAD3 mutaions lead to increased aortic expression of several key players in the TGF-\\u03b2 pathway, including SMAD3; ; observed increased labeling intensity of all these markers (SMAD3, phophorylated and non-phosphorylated, phophorylated SMAD2, TGF-beta1, CTGF) in two individuals with the mutation resulting in p.Arg287Trp\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.\",\"author\":\"Ye P\",\"pubdate\":\"2013 May\",\"source\":\"J Clin Invest\",\"uid\":\"23585475\"},{\"title\":\"SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS.\",\"author\":\"Tan CK\",\"pubdate\":\"2013 Jun 19\",\"source\":\"J Am Heart Assoc\",\"uid\":\"23782924\"}],\"notes\":{\"note\":\"PMID 23585475: mice lacking\\u00a0Smad3\\u00a0had a vascular phenotype similar to AOS, marked by the progressive development of aneurysms\\r\\nPMID 23782924: Using uniaxial tensile and contractility tests, authors showed that\\u00a0SMAD3\\u00a0deficiency resulted in defective aortic biomechanics and physiological functions, which caused weakening of the aortic wall and predisposed the mice to aortic aneurysms\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12\/20\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"12\/20\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"4088",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM603109":
   {"ontology":"OMIM",
    "curie":"OMIM:603109",
    "uri":"OMIM603109",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_603109"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "5465":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Arthrogryposis",
  "genes":
  {"7608":{"ontology":"HGNC", "curie":"HGNC:7608", "uri":"HGNC7608"}},
  "title":"MYO9A Arthrogryposis",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MYO9A\",\"Hgnc\":\"7608\",\"OrphaNet\":\"ORPHA109007\",\"Disease\":\"Arthrogryposis\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"2.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Myr 7 is a novel myosin IX-RhoGAP expressed in rat brain.\",\"author\":\"Chieregatti E\",\"pubdate\":\"1998 Dec 18\",\"source\":\"J Cell Sci\",\"uid\":\"9819351\"},{\"title\":\"The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22-q23.\",\"author\":\"Gorman SW\",\"pubdate\":\"1999 Jul 15\",\"source\":\"Genomics\",\"uid\":\"10409426\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Myosin-IXA regulates collective epithelial cell migration by targeting RhoGAP activity to cell-cell junctions.\",\"author\":\"Omelchenko T\",\"pubdate\":\"2012 Feb 21\",\"source\":\"Curr Biol\",\"uid\":\"22305756\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"09\/08\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11\/24\/2016\",\"FinalClassificationNotes\":\"The expert scored this at 3 points, which corresponded to a solid Limited classification.\"}}",
  "date":1479974400,
  "file":null,
  "dateISO8601":"2016-11-24T00:00:00",
  "entrez_id":"4649",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015225"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA109007":
   {"ontology":"ORPHA",
    "curie":"ORPHA:109007",
    "uri":"ORPHA109007",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_109007"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Nov 24, 2016",
  "scoreJsonSerializedSop5":""},
 "8268":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:3604":
   {"ontology":"HGNC", "curie":"HGNC:3604", "uri":"HGNC3604"}},
  "title":
  "FBN2 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"FBN2\",\"Hgnc\":\"3604\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"612570\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature.\",\"author\":\"Callewaert BL\",\"pubdate\":\"2009 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"19006240\"},{\"title\":\"Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: Case report and review of literature.\",\"author\":\"Takeda N\",\"pubdate\":\"2015 Oct\",\"source\":\"Am J Med Genet A\",\"uid\":\"25975422\"},{\"title\":\"Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development.\",\"author\":\"Park ES\",\"pubdate\":\"1998 Jul 24\",\"source\":\"Am J Med Genet\",\"uid\":\"9714438\"}],\"notes\":{\"note\":\"19006240 Proband with mild aortic dilation harboring p.Ser1122Pro\\r\\n25975422 Proband with mild aortic dilation harboring IVS 32 + 5 G>A\\r\\n9714438 Paediatric aortic root dilatation. Variant IVS31+1G>C\\r\\n Weak evidence . Total points for isolated thoracic aortic aneurysm and aortic dissection (TAAD) =1\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Fibrillins 1 and 2 perform partially overlapping functions during aortic development.\",\"author\":\"Carta L\",\"pubdate\":\"2006 Mar 24\",\"source\":\"J Biol Chem\",\"uid\":\"16407178\"},{\"title\":\"Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.\",\"author\":\"Zhang H\",\"pubdate\":\"1994 Mar\",\"source\":\"J Cell Biol\",\"uid\":\"8120105\"},{\"title\":\"Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases.\",\"author\":\"Davis MR\",\"pubdate\":\"2012 Dec\",\"source\":\"Mol Genet Metab\",\"uid\":\"22921888\"}],\"notes\":{\"note\":\"Biochemical function\\r\\nPMID 16407178: FBN2-\/- ;FBN1+\/- mice have impaired elastogenesis compared with FBN1-\/- alone - implies synergistic roles of FBN1 and 2 in fibre formation.\\r\\nPMID 8120105: immunohistochemistry and ultrastructural analysis localise FBN2 to formation of microfibrils in human and bovine fetal tissue, presence enriched in elastic fibre-rich areas eg aortic media.\\r\\nPMID 22921888: immunohistochemistry to show that FBN2 forms microfibrils. \\r\\nExpression\\r\\nPMID 8120105: expression enriched in elastic fibre-rich areas eg aortic media\\r\\nProtein interaction\\r\\nPMID 16407178: FBN2-\/- ;FBN1+\/- mice have impaired elastogenesis compared with FBN1-\/- alone - implies synergistic roles of FBN1 and 2 in fibre formation.\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Fibrillins 1 and 2 perform partially overlapping functions during aortic development.\",\"author\":\"Carta L\",\"pubdate\":\"2006 Mar 24\",\"source\":\"J Biol Chem\",\"uid\":\"16407178\"}],\"notes\":{\"note\":\"FBN2-\/- ;FBN1+\/- mice have impaired elastogenesis compared with FBN1-\/- alone - implies synergistic roles of FBN1 and 2 in fibre formation. Double knockouts (FBN1-\/-;FBN2-\/-) are  non-viable just after embryonic day 14.5.\\t\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"4\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04\/17\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"04\/17\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nFBN2 is clearly associated with congenital contractural arachnodactyly, however, not with HTAAD. FBN2 could be predictive of thoracic aortic enlargement without evidence of progression to aortic dissection so far\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"2201",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM612570":
   {"ontology":"OMIM",
    "curie":"OMIM:612570",
    "uri":"OMIM612570",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_612570"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "10082":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"7765":{"ontology":"HGNC", "curie":"HGNC:7765", "uri":"HGNC7765"}},
  "title":"NF1: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"NF1\",\"Hgnc\":\"7765\",\"OrphaNet\":\"363700\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"162200\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"02\/22\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"02\/22\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1487750400,
  "file":null,
  "dateISO8601":"2017-02-22T00:00:00",
  "entrez_id":"4763",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Feb 22, 2017",
  "scoreJsonSerializedSop5":""},
 "8405":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Nonsyndromic sensorineural hearing loss",
  "genes":
  {"3169":{"ontology":"HGNC", "curie":"HGNC:3169", "uri":"HGNC3169"}},
  "title":"S1PR2: Nonsyndromic sensorineural hearing loss",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"S1PR2\",\"Hgnc\":\"3169\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"610419\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"2.0\",\"tally\":\"2\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"10.0\",\"tally\":\"7\"}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.\",\"author\":\"MacLennan AJ\",\"pubdate\":\"2006 Oct\",\"source\":\"Hear Res\",\"uid\":\"16945494\"},{\"title\":\"Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2.\",\"author\":\"Herr DR\",\"pubdate\":\"2007 Feb 7\",\"source\":\"J Neurosci\",\"uid\":\"17287522\"},{\"title\":\"Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy.\",\"author\":\"Herr DR\",\"pubdate\":\"2016 Apr 15\",\"source\":\"Sci Rep\",\"uid\":\"27080739\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"6.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.\",\"author\":\"MacLennan AJ\",\"pubdate\":\"2006 Oct\",\"source\":\"Hear Res\",\"uid\":\"16945494\"},{\"title\":\"Deafness and stria vascularis defects in S1P2 receptor-null mice.\",\"author\":\"Kono M\",\"pubdate\":\"2007 Apr 6\",\"source\":\"J Biol Chem\",\"uid\":\"17284444\"},{\"title\":\"Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2.\",\"author\":\"Herr DR\",\"pubdate\":\"2007 Feb 7\",\"source\":\"J Neurosci\",\"uid\":\"17287522\"},{\"title\":\"Gene miles-apart is required for formation of otic vesicle and hair cells in zebrafish.\",\"author\":\"Hu ZY\",\"pubdate\":\"2013 Oct 31\",\"source\":\"Cell Death Dis\",\"uid\":\"24176858\"},{\"title\":\"S1PR2 variants associated with auditory function in humans and endocochlear potential decline in mouse.\",\"author\":\"Ingham NJ\",\"pubdate\":\"2016 Jul 7\",\"source\":\"Sci Rep\",\"uid\":\"27383011\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"11\/03\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"03\/02\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hereditary Hearing Loss Working Group\"}}",
  "date":1488441600,
  "file":null,
  "dateISO8601":"2017-03-02T00:00:00",
  "entrez_id":"9294",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019497"},
   "OMIM610419":
   {"ontology":"OMIM",
    "curie":"OMIM:610419",
    "uri":"OMIM610419",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_610419"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3978":{"label":"Strong"}},
  "dateFormated":"Mar 02, 2017",
  "scoreJsonSerializedSop5":""},
 "10158":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:10586":
   {"ontology":"HGNC", "curie":"HGNC:10586", "uri":"HGNC10586"}},
  "title":"SCN1B: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"6324",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530662583\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN1B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10586\",\"uri\":\"HGNC10586\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN1B Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530662970733\":{\"title\":\"SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.\",\"author\":\"Ricci MT\",\"pubdate\":\"2014 Sep 25\",\"source\":\"Sci Rep\",\"uid\":\"25253298\"},\"1530662988808\":{\"title\":\"A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.\",\"author\":\"Hu D\",\"pubdate\":\"2012 May\",\"source\":\"Heart Rhythm\",\"uid\":\"22155597\"},\"1530663058995\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530662959056\":{\"title\":\"Sodium channel \\u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.\",\"author\":\"Watanabe H\",\"pubdate\":\"2008 Jun\",\"source\":\"J Clin Invest\",\"uid\":\"18464934\"},\"1530663283863\":{\"title\":\"SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation.\",\"author\":\"Olesen MS\",\"pubdate\":\"2012 May\",\"source\":\"Heart Rhythm\",\"uid\":\"22155598\"},\"1530663367313\":{\"title\":\"Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation.\",\"author\":\"Aoki H\",\"pubdate\":\"2017 Feb\",\"source\":\"J Arrhythm\",\"uid\":\"28217227\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530662872871\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"},\"1530662892331\":{\"title\":\"Sodium channel \\u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.\",\"author\":\"Watanabe H\",\"pubdate\":\"2008 Jun\",\"source\":\"J Clin Invest\",\"uid\":\"18464934\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.75\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662882702\":{\"title\":\"SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.\",\"author\":\"Ricci MT\",\"pubdate\":\"2014 Sep 25\",\"source\":\"Sci Rep\",\"uid\":\"25253298\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530662900260\":{\"title\":\"Sodium channel \\u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.\",\"author\":\"Watanabe H\",\"pubdate\":\"2008 Jun\",\"source\":\"J Clin Invest\",\"uid\":\"18464934\"},\"1530663329022\":{\"title\":\"Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts.\",\"author\":\"Lin X\",\"pubdate\":\"2015 Mar 15\",\"source\":\"J Physiol\",\"uid\":\"25772295\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"2.25\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"12\/22\/2016\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8705":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:23845":
   {"ontology":"HGNC", "curie":"HGNC:23845", "uri":"HGNC23845"}},
  "title":"SLX4: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"SLX4\",\"Hgnc\":\"23845\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"03\/08\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"03\/08\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1488960000,
  "file":null,
  "dateISO8601":"2017-03-08T00:00:00",
  "entrez_id":"84464",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Mar 08, 2017",
  "scoreJsonSerializedSop5":""},
 "8703":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:21876":
   {"ontology":"HGNC", "curie":"HGNC:21876", "uri":"HGNC21876"}},
  "title":"RINT1: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"RINT1\",\"Hgnc\":\"21876\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"09\/14\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"09\/14\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1473836400,
  "file":null,
  "dateISO8601":"2016-09-14T00:00:00",
  "entrez_id":"60561",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Sep 14, 2016",
  "scoreJsonSerializedSop5":""},
 "6238":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Alstrom syndrome",
  "genes":
  {"428":{"ontology":"HGNC", "curie":"HGNC:428", "uri":"HGNC428"}},
  "title":"ALMS1 Alstrom syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"ALMS1\",\"Hgnc\":\"428\",\"OrphaNet\":\"ORPHA64\",\"Disease\":\"Alstrom syndrome\",\"Omim\":\"203800\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstr\\u00f6m syndrome.\",\"author\":\"Collin GB\",\"pubdate\":\"2002 May\",\"source\":\"Nat Genet\",\"uid\":\"11941369\"},{\"title\":\"Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstr\\u00f6m syndrome.\",\"author\":\"Hearn T\",\"pubdate\":\"2002 May\",\"source\":\"Nat Genet\",\"uid\":\"11941370\"},{\"title\":\"Long-term clinical follow-up and molecular testing for diagnosis of the first Tunisian family with Alstr\\u00f6m syndrome.\",\"author\":\"Chakroun A\",\"pubdate\":\"2016 Sep\",\"source\":\"Eur J Med Genet\",\"uid\":\"27523285\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"20.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstr\\u00f6m syndrome.\",\"author\":\"Collin GB\",\"pubdate\":\"2002 May\",\"source\":\"Nat Genet\",\"uid\":\"11941369\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Alms1-disrupted mice recapitulate human Alstr\\u00f6m syndrome.\",\"author\":\"Collin GB\",\"pubdate\":\"2005 Aug 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16000322\"},{\"title\":\"Alstr\\u00f6m Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity.\",\"author\":\"Jagger D\",\"pubdate\":\"2011 Feb 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"21071598\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10\/13\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/10\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1486713600,
  "file":null,
  "dateISO8601":"2017-02-10T00:00:00",
  "entrez_id":"7840",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0008763"},
   "OMIM203800":
   {"ontology":"OMIM",
    "curie":"OMIM:203800",
    "uri":"OMIM203800",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_203800"},
   "ORPHA64":
   {"ontology":"ORPHA",
    "curie":"ORPHA:64",
    "uri":"ORPHA64",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_64"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 10, 2017",
  "scoreJsonSerializedSop5":""},
 "3207":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Dyskeratosis Congenita",
  "genes":
  {"HGNC:25522":
   {"ontology":"HGNC", "curie":"HGNC:25522", "uri":"HGNC25522"}},
  "title":"WRAP53  Dyskeratosis Congenita",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"WRAP53\",\"Hgnc\":\"25522\",\"OrphaNet\":\"ORPHA1775\",\"Disease\":\"Dyskeratosis Congenita\",\"Omim\":\"613988\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"3.5\",\"tally\":\"3.5\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"}],\"notes\":{\"note\":\"The expert chose to upgrade the variant points because of the specificity of the phenotype.\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.\",\"author\":\"Freund A\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Cell\",\"uid\":\"25467444\"},{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"},{\"title\":\"WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.\",\"author\":\"Mahmoudi S\",\"pubdate\":\"2010 Nov 2\",\"source\":\"PLoS Biol\",\"uid\":\"21072240\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"},{\"title\":\"Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.\",\"author\":\"Batista LF\",\"pubdate\":\"2011 May 22\",\"source\":\"Nature\",\"uid\":\"21602826\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"},{\"title\":\"WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.\",\"author\":\"Mahmoudi S\",\"pubdate\":\"2010 Nov 2\",\"source\":\"PLoS Biol\",\"uid\":\"21072240\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"3.5\",\"GeneticEvidencePointsTotal\":\"3.5\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"9.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"08\/04\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"01\/25\/2017\",\"FinalClassificationNotes\":\"This gene\/disease relationship was initially classified as limited by the curator. During expert review, the expert added more experimental evidence and it was increased to moderate.\"}}",
  "date":1485331200,
  "file":null,
  "dateISO8601":"2017-01-25T00:00:00",
  "entrez_id":"55135",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015780"},
   "OMIM613988":
   {"ontology":"OMIM",
    "curie":"OMIM:613988",
    "uri":"OMIM613988",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_613988"},
   "ORPHA1775":
   {"ontology":"ORPHA",
    "curie":"ORPHA:1775",
    "uri":"ORPHA1775",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_1775"}},
  "scores":{"3976":{"label":"Moderate"}},
  "dateFormated":"Jan 25, 2017",
  "scoreJsonSerializedSop5":""},
 "5610":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 1",
  "genes":
  {"13733":
   {"ontology":"HGNC", "curie":"HGNC:13733", "uri":"HGNC13733"}},
  "title":"CDH23 Usher Syndrome Type 1",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CDH23\",\"Hgnc\":\"13733\",\"OrphaNet\":\"231169\",\"Disease\":\"Usher Syndrome, Type 1\",\"Omim\":\"276900\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.5\",\"tally\":\"10.5\",\"pmid\":{\"publications\":[{\"title\":\"Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23.\",\"author\":\"Bork JM\",\"pubdate\":\"2001 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"11090341\"},{\"title\":\"CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness.\",\"author\":\"Astuto LM\",\"pubdate\":\"2002 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"12075507\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"9.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23.\",\"author\":\"Bork JM\",\"pubdate\":\"2001 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"11090341\"}],\"notes\":{\"note\":\"\"}}}}},\"TotalGeneticEvidencePoints\":{\"notes\":\"More genetic evidence is available but the curator stopped at the max score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions.\",\"author\":\"Siemens J\",\"pubdate\":\"2002 Nov 12\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"12407180\"}],\"notes\":{\"note\":\"Protein Interaction, Expression\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome.\",\"author\":\"Vach\\u00e9 C\",\"pubdate\":\"2010 Jun\",\"source\":\"Hum Mutat\",\"uid\":\"20513143\"}],\"notes\":{\"note\":\"Patient Cells\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Genomic structure, alternative splice forms and normal and mutant alleles of cadherin 23 (Cdh23).\",\"author\":\"Di Palma F\",\"pubdate\":\"2001 Dec 27\",\"source\":\"Gene\",\"uid\":\"11750125\"},{\"title\":\"An ENU-induced mutation of Cdh23 causes congenital hearing loss, but no vestibular dysfunction, in mice.\",\"author\":\"Manji SS\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Pathol\",\"uid\":\"21689626\"}],\"notes\":{\"note\":\"Animal model. The retinitis pigmentosa phenotype is not found in the mouse models.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09\/15\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01\/30\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1485763200,
  "file":null,
  "dateISO8601":"2017-01-30T00:00:00",
  "entrez_id":"64072",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0010168"},
   "OMIM276900":
   {"ontology":"OMIM",
    "curie":"OMIM:276900",
    "uri":"OMIM276900",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_276900"},
   "ORPHA231169":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231169",
    "uri":"ORPHA231169",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231169"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jan 30, 2017",
  "scoreJsonSerializedSop5":""},
 "3205":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Diamond-Blackfan anemia",
  "genes":
  {"HGNC:10383":
   {"ontology":"HGNC", "curie":"HGNC:10383", "uri":"HGNC10383"}},
  "title":"RPS10  Diamond-Blackfan anemia",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"RPS10\",\"Hgnc\":\"10383\",\"OrphaNet\":\"ORPHA124\",\"Disease\":\"Diamond-Blackfan anemia\",\"Omim\":\"613308\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.\",\"author\":\"Doherty L\",\"pubdate\":\"2010 Feb 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"20116044\"},{\"title\":\"Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.\",\"author\":\"Smetanina NS\",\"pubdate\":\"2015 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"25946618\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.\",\"author\":\"Doherty L\",\"pubdate\":\"2010 Feb 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"20116044\"},{\"title\":\"Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.\",\"author\":\"Smetanina NS\",\"pubdate\":\"2015 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"25946618\"},{\"title\":\"A novel mutation of ribosomal protein S10 gene in a Japanese patient with diamond-Blackfan anemia.\",\"author\":\"Yazaki M\",\"pubdate\":\"2012 May\",\"source\":\"J Pediatr Hematol Oncol\",\"uid\":\"22510774\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A census of human soluble protein complexes.\",\"author\":\"Havugimana PC\",\"pubdate\":\"2012 Aug 31\",\"source\":\"Cell\",\"uid\":\"22939629\"},{\"title\":\"A high-throughput approach for measuring temporal changes in the interactome.\",\"author\":\"Kristensen AR\",\"pubdate\":\"2012 Sep\",\"source\":\"Nat Methods\",\"uid\":\"22863883\"},{\"title\":\"Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.\",\"author\":\"Doherty L\",\"pubdate\":\"2010 Feb 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"20116044\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07\/04\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01\/19\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1484812800,
  "file":null,
  "dateISO8601":"2017-01-19T00:00:00",
  "entrez_id":"6204",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015253"},
   "OMIM613308":
   {"ontology":"OMIM",
    "curie":"OMIM:613308",
    "uri":"OMIM613308",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_613308"},
   "ORPHA124":
   {"ontology":"ORPHA",
    "curie":"ORPHA:124",
    "uri":"ORPHA124",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_124"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jan 19, 2017",
  "scoreJsonSerializedSop5":""},
 "8260":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:1044":
   {"ontology":"HGNC", "curie":"HGNC:1044", "uri":"HGNC1044"}},
  "title":
  "BGN : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"BGN\",\"Hgnc\":\"1044\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"301870\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"marfanoid skeletal features in sister; aortic root echocardiographic dimensions at the upper limits of normal in the mother. variant: c.908A>C, p.Gln303Pro . Points=1.5\\r\\nProband with c.238G>A, p.Gly80Ser wih syndromic TAAD. Points =1.5\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"All following probands associated with syndromic thoracic aortic aneurysm and aortic dissection (TAAD).\\r\\nc.5G>A, p.Trp2* variant in a proband with some segregation evidence.\\r\\n21 kb del: chrX:152767424-152787984\\r\\n28 kb del: chrX:152768438-152795976\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"Based on 5 segregations of 21 kb deletion with syndromic form of TAAD. LOD 1.5\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}},\"TotalGeneticEvidencePoints\":{\"notes\":\"Only the proband with isolated TAAD was scored\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Biglycan deficiency causes spontaneous aortic dissection and rupture in mice.\",\"author\":\"Heegaard AM\",\"pubdate\":\"2007 May 29\",\"source\":\"Circulation\",\"uid\":\"17502576\"}],\"notes\":{\"note\":\"Expression:\\r\\nPMID 17502576: BGN localization in the aortas of WT mice was determined by immunohistochemistry and immuno-electron microscopy; BGN detected in all 3 layers of the aortic wall with adventitia the major site of BGN deposition in the mouse. Points 0.5\\r\\n\\r\\nBiochemical Function:\\r\\nPMID 17502576:Resistance to radial elongation of aortic ring specimens from male bgn-KO and WT mice was compared; The maximum load withstood by KO aortic specimens and their maximum stiffness were significantly lower compared with WT. Points= 0.5\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"Patient cells:\\r\\nThree alternatively spliced products were observed in cDNA from cultured skin fibroblasts ; major splice products introduce a premature stop codon leading to NMD.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Biglycan deficiency causes spontaneous aortic dissection and rupture in mice.\",\"author\":\"Heegaard AM\",\"pubdate\":\"2007 May 29\",\"source\":\"Circulation\",\"uid\":\"17502576\"}],\"notes\":{\"note\":\"Biglycan deficiency in male BALB\/cA mice has been shown to lead to sudden death due to aortic rupture.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"5.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11\/17\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nStrong\\u201d for syndromic , X-linked TAAD and \\u201climited\\u201d for isolated TAAD.\\r\\nThe curation shows strong assertion with syndromic TAAD. There was 1 reported proband with isolated TAAD harboring variant in this gene. Given this, the association with isolated TAAD should be limited.\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"633",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM301870":
   {"ontology":"OMIM",
    "curie":"OMIM:301870",
    "uri":"OMIM301870",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_301870"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "8503":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:1748":
   {"ontology":"HGNC", "curie":"HGNC:1748", "uri":"HGNC1748"}},
  "title":"CDH1: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CDH1\",\"Hgnc\":\"1748\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"01\/25\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"08\/03\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1501743600,
  "file":null,
  "dateISO8601":"2017-08-03T00:00:00",
  "entrez_id":"999",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Aug 03, 2017",
  "scoreJsonSerializedSop5":""},
 "8694":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:8975":
   {"ontology":"HGNC", "curie":"HGNC:8975", "uri":"HGNC8975"}},
  "title":"PIK3CA: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"PIK3CA\",\"Hgnc\":\"8975\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"02\/08\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"02\/08\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1486540800,
  "file":null,
  "dateISO8601":"2017-02-08T00:00:00",
  "entrez_id":"5290",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Feb 08, 2017",
  "scoreJsonSerializedSop5":""},
 "8524":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Hereditary breast cancer",
  "genes":
  {"HGNC:6954":
   {"ontology":"HGNC", "curie":"HGNC:6954", "uri":"HGNC6954"}},
  "title":"MCPH1: Hereditary breast cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MCPH1\",\"Hgnc\":\"6954\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.\",\"author\":\"Mantere T\",\"pubdate\":\"2016 Jan\",\"source\":\"PLoS Genet\",\"uid\":\"26820313\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"BRIT1\/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.\",\"author\":\"Lin SY\",\"pubdate\":\"2005 Oct 18\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"16217032\"},{\"title\":\"BRIT1\/MCPH1 links chromatin remodelling to DNA damage response.\",\"author\":\"Peng G\",\"pubdate\":\"2009 Jul\",\"source\":\"Nat Cell Biol\",\"uid\":\"19525936\"},{\"title\":\"BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.\",\"author\":\"Rai R\",\"pubdate\":\"2006 Aug\",\"source\":\"Cancer Cell\",\"uid\":\"16872911\"},{\"title\":\"Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair.\",\"author\":\"Wu X\",\"pubdate\":\"2009 Jul 1\",\"source\":\"Cancer Res\",\"uid\":\"19549900\"},{\"title\":\"BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.\",\"author\":\"Zhang B\",\"pubdate\":\"2013 Oct\",\"source\":\"Carcinogenesis\",\"uid\":\"23729656\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.\",\"author\":\"Mantere T\",\"pubdate\":\"2016 Jan\",\"source\":\"PLoS Genet\",\"uid\":\"26820313\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.\",\"author\":\"Rai R\",\"pubdate\":\"2006 Aug\",\"source\":\"Cancer Cell\",\"uid\":\"16872911\"},{\"title\":\"Mcph1\/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model.\",\"author\":\"Liang Y\",\"pubdate\":\"2015 Aug 13\",\"source\":\"Oncogene\",\"uid\":\"25362854\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01\/11\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"01\/11\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1484121600,
  "file":null,
  "dateISO8601":"2017-01-11T00:00:00",
  "entrez_id":"79648",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016419"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA227535":
   {"ontology":"ORPHA",
    "curie":"ORPHA:227535",
    "uri":"ORPHA227535",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_227535"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Jan 11, 2017",
  "scoreJsonSerializedSop5":""},
 "8434":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"HGNC:1785":
   {"ontology":"HGNC", "curie":"HGNC:1785", "uri":"HGNC1785"}},
  "title":"CDKN1B: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CDKN1B\",\"Hgnc\":\"1785\",\"OrphaNet\":\"ORPHA443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.\",\"author\":\"Smartt HJ\",\"pubdate\":\"2007 Jul\",\"source\":\"Gastroenterology\",\"uid\":\"17631145\"},{\"title\":\"p27kip1 deficiency impairs G2\/M arrest in response to DNA damage, leading to an increase in genetic instability.\",\"author\":\"Payne SR\",\"pubdate\":\"2008 Jan\",\"source\":\"Mol Cell Biol\",\"uid\":\"17954563\"},{\"title\":\"Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.\",\"author\":\"Thomas GV\",\"pubdate\":\"1998 Sep\",\"source\":\"Am J Pathol\",\"uid\":\"9736017\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"The murine gene p27Kip1 is haplo-insufficient for tumour suppression.\",\"author\":\"Fero ML\",\"pubdate\":\"1998 Nov 12\",\"source\":\"Nature\",\"uid\":\"9823898\"},{\"title\":\"Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.\",\"author\":\"Philipp-Staheli J\",\"pubdate\":\"2002 May\",\"source\":\"Cancer Cell\",\"uid\":\"12086850\"},{\"title\":\"Tumorigenesis in p27\/p53- and p18\/p53-double null mice: functional collaboration between the pRb and p53 pathways.\",\"author\":\"Damo LA\",\"pubdate\":\"2005 Feb\",\"source\":\"Mol Carcinog\",\"uid\":\"15584024\"},{\"title\":\"Comparative effects of overexpression of p27Kip1 and p21Cip1\/Waf1 on growth and differentiation in human colon carcinoma cells.\",\"author\":\"Yamamoto H\",\"pubdate\":\"1999 Jan 7\",\"source\":\"Oncogene\",\"uid\":\"9926925\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"4.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01\/10\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"06\/08\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1496905200,
  "file":null,
  "dateISO8601":"2017-06-08T00:00:00",
  "entrez_id":"1027",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Jun 08, 2017",
  "scoreJsonSerializedSop5":""},
 "8274":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:3754":
   {"ontology":"HGNC", "curie":"HGNC:3754", "uri":"HGNC3754"}},
  "title":
  "FLNA : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"FLNA\",\"Hgnc\":\"3754\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"300017\",\"ModeOfInheritance\":\"X-Linked inheritance (HP:0001417)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A.\",\"author\":\"Reinstein E\",\"pubdate\":\"2013 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"23032111\"}],\"notes\":{\"note\":\"Case M3 = 2 month old male\\r\\nde novo c.5498_5504delCACCCACinsAC indel\\r\\nCyanotic post-natally; marked dilatation of whole length of aorta, pulmonary arteries (PAs), Ventricular Septal Defect, Atrial Septal Defect, Patent Ductus Arteriosus. Also post-mortem showed intestinal malrotation.\\r\\nIntractable pulmonary hypertension; died sepsis. \\r\\nNot scored - syndromic - other presenting features\\r\\nCase F3= 6 yo female\\r\\nReferred for murmur; gross dilatation of PA + also aorta + head and neck branches\\r\\np.Tyr731X variant; family study showed this was de novo. Brain MRI shows PNH. \\r\\nNot scored - other presenting features\\r\\n\"}}},\"VariantIsDeNovo\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A.\",\"author\":\"Reinstein E\",\"pubdate\":\"2013 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"23032111\"},{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"}],\"notes\":{\"note\":\"PMID 23032111\\r\\nCase 1 = 38 yo female; SoV aneurysm. Daughter has R subclavian aneurysm; no aortic involvement\\r\\nPeriventricular Nodular Heterotopia on brain MRI; no seizures\\r\\nNonsense mutation in FLNA - p.Asn296Glu fs*38; immunohistochemistry showed 2 fibroblast populations, one of which had no FLNA expression. \\r\\n0.5pt nonsense mutation with evidence of functional effect\\r\\nCase F5 = 23 y\/o female\\r\\nProgressive aortic root dilatation at age 7 (Ix for peripheral cyanosis) + dilated PA\\r\\nSeizures in teens; PNH on brain scan. Joint laxity with recurrent hip subluxations. \\r\\nNonsense variant: c.7813delC (p.Leu2605fs)\\r\\nNot scored (other presenting features)\\r\\nPMID 26188975: Tested 102 patients by WES; reporting of panel of TAA genes. 1 pt found to have nonsense mutation in FLNA (Y1324X). Family pedigree not reported \\u2013 no segregation information. Not in ExAC (synonymous variant at same location)\\r\\n0.5 pt (Due to high pLI score for FLNA, scored 0.5 pt for this proband despite limited info)\\r\\nPMID 15668422: F2 = 16 y\/o F with TAA and EDS \\u2013 like joint laxity \/skin features. Variant = c. 4147 del G\\r\\nTAA major feature; no neurology. No segregation. \\r\\n0.5 pt\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms.\",\"author\":\"Pilop C\",\"pubdate\":\"2009 Sep 15\",\"source\":\"Circulation\",\"uid\":\"19720936\"},{\"title\":\"Calpain-2 compensation promotes angiotensin II-induced ascending and abdominal aortic aneurysms in calpain-1 deficient mice.\",\"author\":\"Subramanian V\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23977256\"}],\"notes\":{\"note\":\"Biochemical Function:\\r\\nPMID 19720936: Role in aortic wall integrity. Increased levels of C terminal fragments of FLNA in dilated aortic walls from BAV and MFS patients.\\r\\nProtein Interactions:\\r\\nPMID 23977256: interaction with angiotensin II: increased C terminal fragmentation with ANgII infusion\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis.\",\"author\":\"Feng Y\",\"pubdate\":\"2006 Dec 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17172441\"},{\"title\":\"Arterial Myogenic Activation through Smooth Muscle Filamin A.\",\"author\":\"Retailleau K\",\"pubdate\":\"2016 Mar 8\",\"source\":\"Cell Rep\",\"uid\":\"26923587\"},{\"title\":\"Smooth muscle filamin A is a major determinant of conduit artery structure and function at the adult stage.\",\"author\":\"Retailleau K\",\"pubdate\":\"2016 Jul\",\"source\":\"Pflugers Arch\",\"uid\":\"27023351\"}],\"notes\":{\"note\":\"PMID 26923587: Mouse with smooth muscle-specific deletion of FLNA at adult stage. Loss of myogenic tone in caudal artery; impaired stretch activation of calcium influx was blunted in the absence of smFlnA: loss of pressure-depndent regulation of arterial tone.\\r\\n\\r\\n\\r\\nPMID 17172441: conditional knockout at adult stage in smooth muscle causes hypertrophic remodeling and increased aortic diameter.\\r\\nPMID 27023351: smooth muscle-specific knockout: hemizygous males die by E14.5 from vascular rupture and fragility.; abnormal cell-cell junctions; failure of vascular remodelling.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/03\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"07\/03\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. Initial scoring curator was downsized. Case 1 was allocated only 1 pt based on the fact that the functional evidence was limited and that it was difficult to assess segregation with regards to TAA. Cases present with syndromic pathology (OPD\/Melnick needles) and should not be given any points. Of the remaining female cases, most have neurological problems. FLNA causes cardiac valvular dysplasia with low risk for thoracic aortic disease and primarily diagnosed based on non-vascular features\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"2316",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM300017":
   {"ontology":"OMIM",
    "curie":"OMIM:300017",
    "uri":"OMIM300017",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_300017"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "5662":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Nonsyndromic sensorineural hearing loss",
  "genes":
  {"25033":
   {"ontology":"HGNC", "curie":"HGNC:25033", "uri":"HGNC25033"}},
  "title":"LRTOMT: Nonsyndromic sensorineural hearing loss",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"LRTOMT\",\"Hgnc\":\"25033\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"611451\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2008 Nov\",\"source\":\"Nat Genet\",\"uid\":\"18953341\"},{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"},{\"title\":\"A 1 bp deletion in the dual reading frame deafness gene LRTOMT causes a frameshift from the first into the second reading frame.\",\"author\":\"Vanwesemael M\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"21739586\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"18.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2008 Nov\",\"source\":\"Nat Genet\",\"uid\":\"18953341\"},{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"},{\"title\":\"A 1 bp deletion in the dual reading frame deafness gene LRTOMT causes a frameshift from the first into the second reading frame.\",\"author\":\"Vanwesemael M\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"21739586\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"The c.242G>A mutation in LRTOMT gene is responsible for a high prevalence of deafness in the Moroccan population.\",\"author\":\"Charif M\",\"pubdate\":\"2012 Dec\",\"source\":\"Mol Biol Rep\",\"uid\":\"23053991\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"},{\"title\":\"Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2008 Nov\",\"source\":\"Nat Genet\",\"uid\":\"18953341\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09\/30\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1487145600,
  "file":null,
  "dateISO8601":"2017-02-15T00:00:00",
  "entrez_id":"220074",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0012670"},
   "OMIM611451":
   {"ontology":"OMIM",
    "curie":"OMIM:611451",
    "uri":"OMIM611451",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_611451"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2017",
  "scoreJsonSerializedSop5":""},
 "10152":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:6243":
   {"ontology":"HGNC", "curie":"HGNC:6243", "uri":"HGNC6243"}},
  "title":"KCNE3: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"10008",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530658625\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNE3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6243\",\"uri\":\"HGNC6243\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNE3 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1530658699947\":{\"title\":\"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.\",\"author\":\"Delp\\u00f3n E\",\"pubdate\":\"2008 Aug\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19122847\"},\"1530658713928\":{\"title\":\"KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.\",\"author\":\"Nakajima T\",\"pubdate\":\"2012\",\"source\":\"Circ J\",\"uid\":\"22987075\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"1\":{\"evidence\":{\"publications\":{\"1530658783059\":{\"title\":\"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.\",\"author\":\"Delp\\u00f3n E\",\"pubdate\":\"2008 Aug\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19122847\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530658868097\":{\"title\":\"Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks).\",\"author\":\"Lundquist AL\",\"pubdate\":\"2005 Feb\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"15698834\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530658739721\":{\"title\":\"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.\",\"author\":\"Delp\\u00f3n E\",\"pubdate\":\"2008 Aug\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19122847\"},\"1530658748862\":{\"title\":\"KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.\",\"author\":\"Nakajima T\",\"pubdate\":\"2012\",\"source\":\"Circ J\",\"uid\":\"22987075\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06\/30\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "5461":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Lissencephaly",
  "genes":
  {"HGNC:6486":
   {"ontology":"HGNC", "curie":"HGNC:6486", "uri":"HGNC6486"}},
  "title":"LAMB1 Lissencephaly",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"LAMB1\",\"Hgnc\":\"6486\",\"OrphaNet\":\"352682\",\"Disease\":\"Lissencephaly 5\",\"Omim\":\"615191\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.\",\"author\":\"Radmanesh F\",\"pubdate\":\"2013 Mar 7\",\"source\":\"Am J Hum Genet\",\"uid\":\"23472759\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.\",\"author\":\"Radmanesh F\",\"pubdate\":\"2013 Mar 7\",\"source\":\"Am J Hum Genet\",\"uid\":\"23472759\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Laminin beta1 and gamma1 containing laminins are essential for basement membrane integrity in the zebrafish eye.\",\"author\":\"Lee J\",\"pubdate\":\"2007 Jun\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"17525174\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"8\",\"GeneticEvidencePointsTotal\":\"8\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"9\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"11\/03\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"11\/15\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1479196800,
  "file":null,
  "dateISO8601":"2016-11-15T00:00:00",
  "entrez_id":"3912",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0014077"},
   "OMIM615191":
   {"ontology":"OMIM",
    "curie":"OMIM:615191",
    "uri":"OMIM615191",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_615191"},
   "ORPHA352682":
   {"ontology":"ORPHA",
    "curie":"ORPHA:352682",
    "uri":"ORPHA352682",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_352682"}},
  "scores":{"3976":{"label":"Moderate"}},
  "dateFormated":"Nov 15, 2016",
  "scoreJsonSerializedSop5":""},
 "5664":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 1",
  "genes":
  {"12597":
   {"ontology":"HGNC", "curie":"HGNC:12597", "uri":"HGNC12597"}},
  "title":"USH1C Usher syndrome type 1",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"USH1C\",\"Hgnc\":\"12597\",\"OrphaNet\":\"ORPHA231169\",\"Disease\":\"Usher Syndrome, Type 1\",\"Omim\":\"276904\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C.\",\"author\":\"Verpy E\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973247\"},{\"title\":\"A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene.\",\"author\":\"Bitner-Glindzicz M\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973248\"},{\"title\":\"Two families from New England with usher syndrome type IC with distinct haplotypes.\",\"author\":\"DeAngelis MM\",\"pubdate\":\"2001 Mar\",\"source\":\"Am J Ophthalmol\",\"uid\":\"11239869\"},{\"title\":\"Novel mutations in the USH1C gene in Usher syndrome patients.\",\"author\":\"Aparisi MJ\",\"pubdate\":\"2010 Dec 31\",\"source\":\"Mol Vis\",\"uid\":\"21203349\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"10.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C.\",\"author\":\"Verpy E\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973247\"},{\"title\":\"A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene.\",\"author\":\"Bitner-Glindzicz M\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973248\"},{\"title\":\"Two families from New England with usher syndrome type IC with distinct haplotypes.\",\"author\":\"DeAngelis MM\",\"pubdate\":\"2001 Mar\",\"source\":\"Am J Ophthalmol\",\"uid\":\"11239869\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\"},\"ModelsRescue\":{\"value\":\"5.0\",\"tally\":\"4\"}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08\/29\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1487145600,
  "file":null,
  "dateISO8601":"2017-02-15T00:00:00",
  "entrez_id":"10083",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0010168"},
   "OMIM276904":
   {"ontology":"OMIM",
    "curie":"OMIM:276904",
    "uri":"OMIM276904",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_276904"},
   "ORPHA231169":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231169",
    "uri":"ORPHA231169",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231169"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2017",
  "scoreJsonSerializedSop5":""},
 "9543":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"nonsyndromic sensorineural deafness",
  "genes":
  {"HGNC:17009":
   {"ontology":"HGNC", "curie":"HGNC:17009", "uri":"HGNC17009"}},
  "title":"TRIOBP: nonsyndromic sensorineural deafness",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1496732400,
  "file":null,
  "dateISO8601":"2017-06-06T00:00:00",
  "entrez_id":"11078",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019588"},
   "OMIM609823":
   {"ontology":"OMIM",
    "curie":"OMIM:609823",
    "uri":"OMIM609823",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_609823"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jun 06, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1520285000\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TRIOBP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17009\",\"uri\":\"HGNC17009\"},\"condition\":{\"name\":\"nonsyndromic sensorineural deafness\",\"OrphaNet\":{\"curie\":\"ORPHA:90636\",\"uri\":\"ORPHA90636\"},\"MONDO\":{\"curie\":\"MONDO:0012355\",\"uri\":\"MONDO0012355\"},\"OMIM\":{\"curie\":\"OMIM:609823\",\"uri\":\"OMIM609823\"}},\"title\":\"TRIOBP nonsyndromic sensorineural deafness\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"0\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"21.00\",\"evidence\":{\"publications\":{\"1519327904090\":{\"title\":\"Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.\",\"author\":\"Shahin H\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385458\"},\"1519327920711\":{\"title\":\"Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.\",\"author\":\"Riazuddin S\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385457\"},\"1519327937782\":{\"title\":\"Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss.\",\"author\":\"Diaz-Horta O\",\"pubdate\":\"2012\",\"source\":\"PLoS One\",\"uid\":\"23226338\"},\"1519327949084\":{\"title\":\"Autosomal Recessive Nonsyndromic Hearing Loss: A Case Report with a Mutation in TRIOBP Gene.\",\"author\":\"Fardaei M\",\"pubdate\":\"2015 Fall\",\"source\":\"Int J Mol Cell Med\",\"uid\":\"27014650\"},\"1519327963380\":{\"title\":\"Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations.\",\"author\":\"Gu X\",\"pubdate\":\"2015 Jun\",\"source\":\"Clin Genet\",\"uid\":\"24853665\"},\"1519327978281\":{\"title\":\"Spectrum of DNA variants for non-syndromic deafness in a large cohort from multiple continents.\",\"author\":\"Yan D\",\"pubdate\":\"2016 Aug\",\"source\":\"Hum Genet\",\"uid\":\"27344577\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"12\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"1\":{\"evidence\":{\"publications\":{\"1519328220708\":{\"title\":\"Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.\",\"author\":\"Shahin H\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385458\"},\"1519328232572\":{\"title\":\"Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.\",\"author\":\"Riazuddin S\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385457\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1519328300911\":{\"title\":\"A Large Genome-Wide Association Study of Age-Related Hearing Impairment Using Electronic Health Records.\",\"author\":\"Hoffmann TJ\",\"pubdate\":\"2016 Oct\",\"source\":\"PLoS Genet\",\"uid\":\"27764096\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"Unscored case-control analysis\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1519328465603\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1519328451756\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1519328426942\":{\"title\":\"Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.\",\"author\":\"Shahin H\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385458\"},\"1519328433462\":{\"title\":\"Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.\",\"author\":\"Riazuddin S\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385457\"},\"1519328443300\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1519328470788\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06\/09\/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"06\/26\/2017\",\"FinalClassificationNotes\":\"The TRIOBP gene has been associated with ARNSHL in 24 probands in 6 publications. 16 unique variants (missense, nonsense, frameshift) have been reported in humans, and variants in this gene segregated with disease in >10 additional family members. TRIOBP was first associated with this disease in  humans in 2006 (Riazuddin et al. 2006, Shahin et al. 2006). This gene-disease association is supported by multiple expression and localization studies, studies showing interaction with F-actin in stereocilia, and a deaf mouse model. In summary, TRIOBP is definitively associated with ARNSHL. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss Working Group.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8504":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:1925":
   {"ontology":"HGNC", "curie":"HGNC:1925", "uri":"HGNC1925"}},
  "title":"CHEK1: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CHEK1\",\"Hgnc\":\"1925\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"10\/12\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"10\/12\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1476255600,
  "file":null,
  "dateISO8601":"2016-10-12T00:00:00",
  "entrez_id":"1111",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Oct 12, 2016",
  "scoreJsonSerializedSop5":""},
 "10147":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:1399":
   {"ontology":"HGNC", "curie":"HGNC:1399", "uri":"HGNC1399"}},
  "title":"CACNA2D1: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"781",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530655650\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CACNA2D1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:1399\",\"uri\":\"HGNC1399\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"CACNA2D1 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1530655752065\":{\"title\":\"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.\",\"author\":\"Burashnikov E\",\"pubdate\":\"2010 Dec\",\"source\":\"Heart Rhythm\",\"uid\":\"20817017\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1.5\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530655810080\":{\"title\":\"Targeted disruption of the voltage-dependent calcium channel alpha2\/delta-1-subunit.\",\"author\":\"Fuller-Bicer GA\",\"pubdate\":\"2009 Jul\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19429829\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530655788078\":{\"title\":\"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.\",\"author\":\"Fagerberg L\",\"pubdate\":\"2014 Feb\",\"source\":\"Mol Cell Proteomics\",\"uid\":\"24309898\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530655933186\":{\"title\":\"Functional characterization of CaV\\u03b12\\u03b4 mutations associated with sudden cardiac death.\",\"author\":\"Bourdin B\",\"pubdate\":\"2015 Jan 30\",\"source\":\"J Biol Chem\",\"uid\":\"25527503\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10\/05\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "3210":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Aneurysm-osteoarthritis syndrome",
  "genes":
  {"HGNC:6769":
   {"ontology":"HGNC", "curie":"HGNC:6769", "uri":"HGNC6769"}},
  "title":"SMAD3  Aneurysm-osteoarthritis syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"SMAD3\",\"Hgnc\":\"6769\",\"OrphaNet\":\"ORPHA284984\",\"Disease\":\"Aneurysm-osteoarthritis syndrome\",\"Omim\":\"613795\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"},{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"},{\"title\":\"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2012 Jan\",\"source\":\"J Med Genet\",\"uid\":\"22167769\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"},{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"},{\"title\":\"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2012 Jan\",\"source\":\"J Med Genet\",\"uid\":\"22167769\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"},{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"}],\"notes\":{\"note\":\"\"}}}}},\"TotalGeneticEvidencePoints\":{\"notes\":\"Additional genetic evidence is available, but not curated due to achievement of maximum genetic evidence score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Transforming growth factor-beta and fibrosis.\",\"author\":\"Verrecchia F\",\"pubdate\":\"2007 Jun 14\",\"source\":\"World J Gastroenterol\",\"uid\":\"17589920\"},{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"TGF-beta\/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage.\",\"author\":\"Yang X\",\"pubdate\":\"2001 Apr 2\",\"source\":\"J Cell Biol\",\"uid\":\"11285272\"},{\"title\":\"SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS.\",\"author\":\"Tan CK\",\"pubdate\":\"2013 Jun 19\",\"source\":\"J Am Heart Assoc\",\"uid\":\"23782924\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03\/30\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12\/01\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1480579200,
  "file":null,
  "dateISO8601":"2016-12-01T00:00:00",
  "entrez_id":"4088",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0013426"},
   "OMIM613795":
   {"ontology":"OMIM",
    "curie":"OMIM:613795",
    "uri":"OMIM613795",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_613795"},
   "ORPHA284984":
   {"ontology":"ORPHA",
    "curie":"ORPHA:284984",
    "uri":"ORPHA284984",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_284984"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Dec 01, 2016",
  "scoreJsonSerializedSop5":""},
 "5657":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 1",
  "genes":
  {"14674":
   {"ontology":"HGNC", "curie":"HGNC:14674", "uri":"HGNC14674"}},
  "title":"PCDH15 Usher syndrome type 1",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"PCDH15\",\"Hgnc\":\"14674\",\"OrphaNet\":\"ORPHA231169\",\"Disease\":\"Usher syndrome type 1F\",\"Omim\":\"602083\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2001 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"11398101\"},{\"title\":\"Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2001 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"11487575\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"16.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2001 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"11398101\"},{\"title\":\"Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2001 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"11487575\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2001 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"11398101\"},{\"title\":\"Photoreceptor expression of the Usher syndrome type 1 protein protocadherin 15 (USH1F) and its interaction with the scaffold protein harmonin (USH1C).\",\"author\":\"Reiners J\",\"pubdate\":\"2005 May 12\",\"source\":\"Mol Vis\",\"uid\":\"15928608\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2001 Jan\",\"source\":\"Nat Genet\",\"uid\":\"11138007\"},{\"title\":\"A new spontaneous mutation in the mouse Ames waltzer gene, Pcdh15.\",\"author\":\"Hampton LL\",\"pubdate\":\"2003 Jun\",\"source\":\"Hear Res\",\"uid\":\"12782354\"},{\"title\":\"Drosophila melanogaster Cad99C, the orthologue of human Usher cadherin PCDH15, regulates the length of microvilli.\",\"author\":\"D\",\"pubdate\":\"2005 Nov 7\",\"source\":\"J Cell Biol\",\"uid\":\"16260500\"},{\"title\":\"Duplicated genes with split functions: independent roles of protocadherin15 orthologues in zebrafish hearing and vision.\",\"author\":\"Seiler C\",\"pubdate\":\"2005 Feb\",\"source\":\"Development\",\"uid\":\"15634702\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08\/16\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1487145600,
  "file":null,
  "dateISO8601":"2017-02-15T00:00:00",
  "entrez_id":"65217",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0010168"},
   "OMIM602083":
   {"ontology":"OMIM",
    "curie":"OMIM:602083",
    "uri":"OMIM602083",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_602083"},
   "ORPHA231169":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231169",
    "uri":"ORPHA231169",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231169"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2017",
  "scoreJsonSerializedSop5":""},
 "8258":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:6664":
   {"ontology":"HGNC", "curie":"HGNC:6664", "uri":"HGNC6664"}},
  "title":
  "LOX : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"LOX\",\"Hgnc\":\"6664\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"153455\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"PMID 26838787: WES in one family with thoracic aortic aneurysm and aortic dissection (TAAD) identified a rare coding variant in LOX; exome and\/or Sanger sequencing of LOX performed in an additional 410 probands from unrelated families.\\r\\n8 rare coding variants identified - 6 probands with variants predicted to be damaging to protein (4 missense mutations were considered to be affecting the final protein) . Points=3 *0.5+ 1\\r\\n\\r\\n\\r\\nPMID 27432961: WES in two first cousins with TAAD identified a rare missense mutation in LOX that co-segregated with disease in a family with a two-generational history of aortic dissection. Points=.5\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"}],\"notes\":{\"note\":\"Two nonsense mutations early in the protein W42* and G202*. Points=3\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"PMIDs 26838787 and 27432961: Only family with p.Ser280Arg considered for segregation evidence( TAA602). Inferred LOD score from 6 segregations (combined families). Point= 3\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Immunohistochemical localization of lysyl oxidase with monoclonal antibodies.\",\"author\":\"Wakasaki H\",\"pubdate\":\"1990 Sep\",\"source\":\"Lab Invest\",\"uid\":\"1975633\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"Biochemical Function:\\r\\nPMID 26838787: Aortas from two patients with LOX variants, Ser280Arg and Gly202*, showed mild medial degeneration characterized by focal loss of elastin fibers and smooth muscle cells (SMCs) but limited deposition of proteoglycans.\\r\\nPMID 27432961: Histopathological analysis of resected aortic tissue (II-1) showed cystic medial necrosis with a disorganized appearance of collagen and elastic lamellae.\\r\\n\\r\\nExpression:\\r\\nPMID 1975633: Localization of lysyl oxidase investigated in various tissues and cultured cells using an immunofluorescent antibody method; monoclonal antibodies showed strong immunostaining in the aorta and dermal connective tissue suggesting a close relation to elastin and collagen.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"Non-patient cells\\r\\n\\r\\nPMID 26838787: Mutant LOX constructs expressed in Hela cells assayed for lysyl oxidase activity; Thr248Ile, Ser280Arg, and Ser348Arg had lysyl oxidase activity levels that were 92%, 50%, and 79% of that of WT LOX, respectively.\\r\\nPMID 27432961:Lox activity in MEFs cultured from WT animals significantly higher than that from homozygous mutant knock-in animals.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.\",\"author\":\"M\\u00e4ki JM\",\"pubdate\":\"2002 Nov 5\",\"source\":\"Circulation\",\"uid\":\"12417550\"},{\"title\":\"Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.\",\"author\":\"M\\u00e4ki JM\",\"pubdate\":\"2002 Nov 5\",\"source\":\"Circulation\",\"uid\":\"12417550\"},{\"title\":\"Lysyl oxidase is required for vascular and diaphragmatic development in mice.\",\"author\":\"Hornstra IK\",\"pubdate\":\"2003 Apr 18\",\"source\":\"J Biol Chem\",\"uid\":\"12473682\"}],\"notes\":{\"note\":\"PMID 12417550: Cre-Lox mediated targeted deletion of first exon; mixed 129\/SvJ \\u00d7 C57BL\/6 background\\r\\nLOX(\\u2212\/\\u2212) mice died at the end of gestation or as neonates; necropsy of the live-born pups revealed large aortic aneurysms\\r\\nMicroscopic analysis of the aorta demonstrated highly fragmented elastic fibers and discontinuity in the smooth muscle cell layers\\r\\nPMID 12473682: LoxP mediated disruption of first exon; mixed 129\/SvJ \\u00d7 C57BL\/6 background\\r\\nLOX(\\u2212\/\\u2212) mice died soon after parturition, exhibiting cardiovascular instability with ruptured arterial aneurysms and diaphragmatic rupture. Microscopic analysis of the aorta demonstrated fragmented elastic fiber architecture\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"05\/13\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"STRONG\",\"CuratorClassificationDate\":\"05\/13\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"07\/25\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
  "date":1469430000,
  "file":null,
  "dateISO8601":"2016-07-25T00:00:00",
  "entrez_id":"4015",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM153455":
   {"ontology":"OMIM",
    "curie":"OMIM:153455",
    "uri":"OMIM153455",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_153455"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3978":{"label":"Strong"}},
  "dateFormated":"Jul 25, 2016",
  "scoreJsonSerializedSop5":""},
 "8151":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 2",
  "genes":
  {"16361":
   {"ontology":"HGNC", "curie":"HGNC:16361", "uri":"HGNC16361"}},
  "title":"WHRN: Usher syndrome type 2",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"WHRN\",\"Hgnc\":\"16361\",\"OrphaNet\":\"231178\",\"Disease\":\"Usher syndrome type 2\",\"Omim\":\"611383\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.\",\"author\":\"Ebermann I\",\"pubdate\":\"2007 Apr\",\"source\":\"Hum Genet\",\"uid\":\"17171570\"},{\"title\":\"A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family.\",\"author\":\"Audo I\",\"pubdate\":\"2011\",\"source\":\"Mol Vis\",\"uid\":\"21738389\"},{\"title\":\"Non-USH2A mutations in USH2 patients.\",\"author\":\"Besnard T\",\"pubdate\":\"2012 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"22147658\"},{\"title\":\"Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: high rate of ethnicity specific mutations in Chinese USH patients.\",\"author\":\"Jiang L\",\"pubdate\":\"2015 Sep 4\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"26338283\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.\",\"author\":\"Ebermann I\",\"pubdate\":\"2007 Apr\",\"source\":\"Hum Genet\",\"uid\":\"17171570\"},{\"title\":\"A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family.\",\"author\":\"Audo I\",\"pubdate\":\"2011\",\"source\":\"Mol Vis\",\"uid\":\"21738389\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31.\",\"author\":\"Mburu P\",\"pubdate\":\"2003 Aug\",\"source\":\"Nat Genet\",\"uid\":\"12833159\"},{\"title\":\"The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1.\",\"author\":\"van Wijk E\",\"pubdate\":\"2006 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"16434480\"},{\"title\":\"Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss.\",\"author\":\"Yang J\",\"pubdate\":\"2010 May 20\",\"source\":\"PLoS Genet\",\"uid\":\"20502675\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"8.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31.\",\"author\":\"Mburu P\",\"pubdate\":\"2003 Aug\",\"source\":\"Nat Genet\",\"uid\":\"12833159\"},{\"title\":\"Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss.\",\"author\":\"Yang J\",\"pubdate\":\"2010 May 20\",\"source\":\"PLoS Genet\",\"uid\":\"20502675\"},{\"title\":\"Gene Therapy Restores Balance and Auditory Functions in a Mouse Model of Usher Syndrome.\",\"author\":\"Isgrig K\",\"pubdate\":\"2017 Mar 1\",\"source\":\"Mol Ther\",\"uid\":\"28254438\"},{\"title\":\"Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.\",\"author\":\"Ebrahim S\",\"pubdate\":\"2016 May 3\",\"source\":\"Cell Rep\",\"uid\":\"27117407\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03\/30\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"05\/10\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1494399600,
  "file":null,
  "dateISO8601":"2017-05-10T00:00:00",
  "entrez_id":"25861",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0012662"},
   "OMIM611383":
   {"ontology":"OMIM",
    "curie":"OMIM:611383",
    "uri":"OMIM611383",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_611383"},
   "ORPHA231178":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231178",
    "uri":"ORPHA231178",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231178"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"May 10, 2017",
  "scoreJsonSerializedSop5":""},
 "9862":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"16627":
   {"ontology":"HGNC", "curie":"HGNC:16627", "uri":"HGNC16627"}},
  "title":"CHEK2: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CHEK2\",\"Hgnc\":\"16627\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"604373\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.25\",\"pmid\":{\"publications\":[{\"title\":\"Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.\",\"author\":\"Yurgelun MB\",\"pubdate\":\"2017 Apr 1\",\"source\":\"J Clin Oncol\",\"uid\":\"28135145\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Homozygous inactivation of <i>CHEK2<\/i> is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs.\",\"author\":\"Kukita Y\",\"pubdate\":\"2016 Nov\",\"source\":\"Cold Spring Harb Mol Case Stud\",\"uid\":\"27900359\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.5\",\"tally\":\"2.5\",\"pmid\":{\"publications\":[{\"title\":\"Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.\",\"author\":\"Xiang HP\",\"pubdate\":\"2011 Nov\",\"source\":\"Eur J Cancer\",\"uid\":\"21807500\"},{\"title\":\"CHEK2 mutations and HNPCC-related colorectal cancer.\",\"author\":\"Suchy J\",\"pubdate\":\"2010 Jun 15\",\"source\":\"Int J Cancer\",\"uid\":\"19876921\"},{\"title\":\"The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.\",\"author\":\"Meijers-Heijboer H\",\"pubdate\":\"2003 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"12690581\"},{\"title\":\"The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.\",\"author\":\"Kleibl Z\",\"pubdate\":\"2009 Mar\",\"source\":\"Eur J Cancer\",\"uid\":\"18996005\"},{\"title\":\"CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.\",\"author\":\"Wasielewski M\",\"pubdate\":\"2008 Aug 1\",\"source\":\"Clin Cancer Res\",\"uid\":\"18676774\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.\",\"author\":\"van Puijenbroek M\",\"pubdate\":\"2005 Jun\",\"source\":\"J Pathol\",\"uid\":\"15818573\"},{\"title\":\"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.\",\"author\":\"Bartkova J\",\"pubdate\":\"2005 Apr 14\",\"source\":\"Nature\",\"uid\":\"15829956\"},{\"title\":\"DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response.\",\"author\":\"Freiberg RA\",\"pubdate\":\"2006 Mar\",\"source\":\"Mol Cell Biol\",\"uid\":\"16478982\"},{\"title\":\"Alterations of Chk1 and Chk2 expression in colon cancer.\",\"author\":\"Stawinska M\",\"pubdate\":\"2008 Dec\",\"source\":\"Int J Colorectal Dis\",\"uid\":\"18679694\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.\",\"author\":\"Ertych N\",\"pubdate\":\"2014 Aug\",\"source\":\"Nat Cell Biol\",\"uid\":\"24976383\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"3.25\",\"GeneticEvidencePointsTotal\":\"3.25\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"5.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"03\/13\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03\/13\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1489388400,
  "file":null,
  "dateISO8601":"2017-03-13T00:00:00",
  "entrez_id":"11200",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM604373":
   {"ontology":"OMIM",
    "curie":"OMIM:604373",
    "uri":"OMIM604373",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_604373"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Mar 13, 2017",
  "scoreJsonSerializedSop5":""},
 "10062":
 {"affiliation":{"id":"10008", "name":"Hypertrophic Cardiomyopathy"},
  "label":"Mitochondrial syndrome",
  "genes":
  {"HGNC:10990":
   {"ontology":"HGNC", "curie":"HGNC:10990", "uri":"HGNC10990"}},
  "title":"SLC25A4: Mitochondrial syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1504051200,
  "file":null,
  "dateISO8601":"2017-08-30T00:00:00",
  "entrez_id":"291",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0014175"},
   "OMIM615418":
   {"ontology":"OMIM",
    "curie":"OMIM:615418",
    "uri":"OMIM615418",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_615418"},
   "ORPHA":
   {"ontology":"ORPHA",
    "curie":"ORPHA:",
    "uri":"ORPHA",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Aug 30, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1527821018\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SLC25A4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10990\",\"uri\":\"HGNC10990\"},\"condition\":{\"name\":\"Mitochondrial syndrome\",\"MONDO\":{\"curie\":\"MONDO:0014175\",\"uri\":\"MONDO0014175\"},\"OMIM\":{\"curie\":\"OMIM:615418\",\"uri\":\"OMIM615418\"}},\"title\":\"SLC25A4 Mitochondrial syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"6.00\",\"evidence\":{\"publications\":{\"1527821212074\":{\"title\":\"Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy.\",\"author\":\"Echaniz-Laguna A\",\"pubdate\":\"2012 Feb\",\"source\":\"J Med Genet\",\"uid\":\"22187496\"},\"1527821250002\":{\"title\":\"Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.\",\"author\":\"Strauss KA\",\"pubdate\":\"2013 Feb 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"23401503\"},\"1527821268732\":{\"title\":\"Two Novel Mutations in the SLC25A4 Gene in a Patient with Mitochondrial Myopathy.\",\"author\":\"K\\u00f6rver-Keularts IM\",\"pubdate\":\"2015\",\"source\":\"JIMD Rep\",\"uid\":\"25732997\"},\"1527821309713\":{\"title\":\"Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.\",\"author\":\"Bakker HD\",\"pubdate\":\"1993 Apr\",\"source\":\"Pediatr Res\",\"uid\":\"8479824\"}},\"notes\":{\"note\":\"PMIDS 25732997 and  8479824 report the same proband and were evaluated together.\"}}},\"Tally\":\"7.5\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"1.50\",\"evidence\":{\"publications\":{\"1527821232283\":{\"title\":\"Complete loss-of-function of the heart\/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy.\",\"author\":\"Palmieri L\",\"pubdate\":\"2005 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16155110\"}},\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\",\"1\":{\"evidence\":{\"publications\":{\"1527821356565\":{\"title\":\"Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.\",\"author\":\"Strauss KA\",\"pubdate\":\"2013 Feb 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"23401503\"}},\"notes\":{\"note\":\"10 affected over 13 generations but significant consanguineity impedes eLOD calculations. \"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"7.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527821411385\":{\"title\":\"A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart\/muscle isoform of the adenine nucleotide translocator.\",\"author\":\"Graham BH\",\"pubdate\":\"1997 Jul\",\"source\":\"Nat Genet\",\"uid\":\"9207786\"},\"1527821422467\":{\"title\":\"A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed.\",\"author\":\"Li K\",\"pubdate\":\"1989 Aug 25\",\"source\":\"J Biol Chem\",\"uid\":\"2547778\"},\"1527821432514\":{\"title\":\"Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes.\",\"author\":\"Levy SE\",\"pubdate\":\"2000 Aug 22\",\"source\":\"Gene\",\"uid\":\"10974536\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527821460177\":{\"title\":\"A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart\/muscle isoform of the adenine nucleotide translocator.\",\"author\":\"Graham BH\",\"pubdate\":\"1997 Jul\",\"source\":\"Nat Genet\",\"uid\":\"9207786\"},\"1527821482098\":{\"title\":\"Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis.\",\"author\":\"Narula N\",\"pubdate\":\"2011 Jan\",\"source\":\"JACC Cardiovasc Imaging\",\"uid\":\"21232697\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527821504827\":{\"title\":\"Adeno-associated virus-mediated gene transfer of the heart\/muscle adenine nucleotide translocator (ANT) in mouse.\",\"author\":\"Flierl A\",\"pubdate\":\"2005 Apr\",\"source\":\"Gene Ther\",\"uid\":\"15647764\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"7.5\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07\/27\/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"08\/30\/2017\",\"FinalClassificationNotes\":\"Curated as part of the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel and Approved by ClinGen Inborn Errors of Metabolism expert Heather Beaudet.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "10145":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:493":
   {"ontology":"HGNC", "curie":"HGNC:493", "uri":"HGNC493"}},
  "title":"ANK2: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"287",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530654010\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ANK2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:493\",\"uri\":\"HGNC493\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"ANK2 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.90\",\"Tally\":\"2.9\",\"evidence\":{\"publications\":{\"1530654162094\":{\"title\":\"Defining the cellular phenotype of \\\"ankyrin-B syndrome\\\" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2007 Jan 30\",\"source\":\"Circulation\",\"uid\":\"17242276\"},\"1530654192405\":{\"title\":\"Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome.\",\"author\":\"Allegue C\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26230511\"},\"1530654596573\":{\"title\":\"Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes.\",\"author\":\"Ichikawa M\",\"pubdate\":\"2016 Nov 25\",\"source\":\"Circ J\",\"uid\":\"27784853\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2.9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530654299754\":{\"title\":\"Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2004 Dec 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"15579534\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530654285946\":{\"title\":\"Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2004 Dec 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"15579534\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530654324582\":{\"title\":\"Defining the cellular phenotype of \\\"ankyrin-B syndrome\\\" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2007 Jan 30\",\"source\":\"Circulation\",\"uid\":\"17242276\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2.9\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"4.9\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04\/25\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8263":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:6904":
   {"ontology":"HGNC", "curie":"HGNC:6904", "uri":"HGNC6904"}},
  "title":
  "MAT2A : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MAT2A\",\"Hgnc\":\"6904\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601468\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"MAT2A mutations predispose individuals to thoracic aortic aneurysms.\",\"author\":\"Guo DC\",\"pubdate\":\"2015 Jan 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"25557781\"}],\"notes\":{\"note\":\"DNA from two affected family members was used for whole-exome sequencing to identify a rare variant c.1031A>C; (p.Glu344Ala) in MAT2A. \\r\\nVariant is predicted to be damaging by six in silico algorithms + CADD score of 24.\\r\\nSegregates with aortic disease. Proband point=1.5\\r\\nAdditional screening of  individuals with familial thoracic aortic aneurysm and aortic dissection (FTAAD) (78 exome sequencing  and 447 Sanger for all MAT2A exons) identified p.Arg356His variant in one individual. However same individual harbors a rare missense variant in ACTA2. This variant was predicted to be damaging buy six bioinformatic tools.  The functionality of the mutations were tested in zebrafish by morpholino KO and coinjection with  human wild type and mutant mRNA .\\r\\nPoints=0.5\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MAT2A mutations predispose individuals to thoracic aortic aneurysms.\",\"author\":\"Guo DC\",\"pubdate\":\"2015 Jan 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"25557781\"}],\"notes\":{\"note\":\"Linkage analysis of thoracic aortic disease with the MAT2A variant\\r\\n(c.1031A>C) in TAA059 generated a two-point LOD score of 2.31. \\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MAT2A mutations predispose individuals to thoracic aortic aneurysms.\",\"author\":\"Guo DC\",\"pubdate\":\"2015 Jan 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"25557781\"}],\"notes\":{\"note\":\"Morpholino KO in zebrafish leading to pericardial edema and rescue by human MAT2a. Points=2 (model system) +2 (rescue). \"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"07\/03\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"07\/03\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"07\/03\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. Recent gene - no additional mutations in a cohort from unpublished data on >400 patients - points subtracted giving it a final limited classification.\"}}",
  "date":1467529200,
  "file":null,
  "dateISO8601":"2016-07-03T00:00:00",
  "entrez_id":"4144",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM601468":
   {"ontology":"OMIM",
    "curie":"OMIM:601468",
    "uri":"OMIM601468",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601468"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Jul 03, 2016",
  "scoreJsonSerializedSop5":""},
 "9863":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"29170":
   {"ontology":"HGNC", "curie":"HGNC:29170", "uri":"HGNC29170"}},
  "title":"FAN1: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"FAN1\",\"Hgnc\":\"29170\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.\",\"author\":\"Segu\\u00ed N\",\"pubdate\":\"2015 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"26052075\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.25\",\"pmid\":{\"publications\":[{\"title\":\"Deficiency of FANCD2-associated nuclease KIAA1018\/FAN1 sensitizes cells to interstrand crosslinking agents.\",\"author\":\"Kratz K\",\"pubdate\":\"2010 Jul 9\",\"source\":\"Cell\",\"uid\":\"20603016\"},{\"title\":\"A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair.\",\"author\":\"Smogorzewska A\",\"pubdate\":\"2010 Jul 9\",\"source\":\"Mol Cell\",\"uid\":\"20603073\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.\",\"author\":\"Segu\\u00ed N\",\"pubdate\":\"2015 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"26052075\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability.\",\"author\":\"Lachaud C\",\"pubdate\":\"2016 Feb 19\",\"source\":\"Science\",\"uid\":\"26797144\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.25\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"2.25\",\"EvidencePointsTotal\":\"3.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10\/23\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"10\/23\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1508742000,
  "file":null,
  "dateISO8601":"2017-10-23T00:00:00",
  "entrez_id":"22909",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Oct 23, 2017",
  "scoreJsonSerializedSop5":""},
 "5463":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Arthrogryposis",
  "genes":
  {"HGNC:29122":
   {"ontology":"HGNC", "curie":"HGNC:29122", "uri":"HGNC29122"}},
  "title":"VPS8 Arthrogryposis",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"VPS8\",\"Hgnc\":\"HGNC:29122\",\"OrphaNet\":\"ORPHA1037\",\"Disease\":\"Arthrogryposis\",\"Omim\":\"108120\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A novel RING finger protein, Vps8p, functionally interacts with the small GTPase, Vps21p, to facilitate soluble vacuolar protein localization.\",\"author\":\"Horazdovsky BF\",\"pubdate\":\"1996 Dec 27\",\"source\":\"J Biol Chem\",\"uid\":\"8969229\"},{\"title\":\"The N-terminal domains of Vps3 and Vps8 are critical for localization and function of the CORVET tethering complex on endosomes.\",\"author\":\"Epp N\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23840658\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"0\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"0.5\",\"GeneticEvidencePointsTotal\":\"0.5\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"08\/18\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11\/24\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1479974400,
  "file":null,
  "dateISO8601":"2016-11-24T00:00:00",
  "entrez_id":"23355",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015168"},
   "OMIM108120":
   {"ontology":"OMIM",
    "curie":"OMIM:108120",
    "uri":"OMIM108120",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_108120"},
   "ORPHA1037":
   {"ontology":"ORPHA",
    "curie":"ORPHA:1037",
    "uri":"ORPHA1037",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_1037"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Nov 24, 2016",
  "scoreJsonSerializedSop5":""},
 "5466":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Myofibrillar Myopathy",
  "genes":
  {"HGNC:939":
   {"ontology":"HGNC", "curie":"HGNC:939", "uri":"HGNC939"}},
  "title":"BAG3 Myofibrillar Myopathy",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"BAG3\",\"Hgnc\":\"HGNC:939\",\"OrphaNet\":\"ORPHA593\",\"Disease\":\"myofibrillar myopathy 6\",\"Omim\":\"612954\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutation in BAG3 causes severe dominant childhood muscular dystrophy.\",\"author\":\"Selcen D\",\"pubdate\":\"2009 Jan\",\"source\":\"Ann Neurol\",\"uid\":\"19085932\"},{\"title\":\"Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation.\",\"author\":\"Odgerel Z\",\"pubdate\":\"2010 Jul\",\"source\":\"Neuromuscul Disord\",\"uid\":\"20605452\"},{\"title\":\"Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.\",\"author\":\"Semmler AL\",\"pubdate\":\"2014 Aug 1\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"25208129\"},{\"title\":\"BAG3 myofibrillar myopathy presenting with cardiomyopathy.\",\"author\":\"Konersman CG\",\"pubdate\":\"2015 May\",\"source\":\"Neuromuscul Disord\",\"uid\":\"25728519\"},{\"title\":\"BAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndrome.\",\"author\":\"Kostera-Pruszczyk A\",\"pubdate\":\"2015 Dec\",\"source\":\"J Muscle Res Cell Motil\",\"uid\":\"26545904\"},{\"title\":\"Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.\",\"author\":\"D\",\"pubdate\":\"2016 Jun\",\"source\":\"J Muscle Res Cell Motil\",\"uid\":\"27443559\"},{\"title\":\"BAG3 mutations: another cause of giant axonal neuropathy.\",\"author\":\"Jaffer F\",\"pubdate\":\"2012 Jun\",\"source\":\"J Peripher Nerv Syst\",\"uid\":\"22734908\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"BAG3 deficiency results in fulminant myopathy and early lethality.\",\"author\":\"Homma S\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Pathol\",\"uid\":\"16936253\"},{\"title\":\"Mutation in BAG3 causes severe dominant childhood muscular dystrophy.\",\"author\":\"Selcen D\",\"pubdate\":\"2009 Jan\",\"source\":\"Ann Neurol\",\"uid\":\"19085932\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"6.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"BAG3 deficiency results in fulminant myopathy and early lethality.\",\"author\":\"Homma S\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Pathol\",\"uid\":\"16936253\"},{\"title\":\"BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress.\",\"author\":\"Hishiya A\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Circ Res\",\"uid\":\"20884878\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"7\",\"GeneticEvidencePointsTotal\":\"7\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12\/18\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1482048000,
  "file":null,
  "dateISO8601":"2016-12-18T00:00:00",
  "entrez_id":"9531",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018943"},
   "OMIM612954":
   {"ontology":"OMIM",
    "curie":"OMIM:612954",
    "uri":"OMIM612954",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_612954"},
   "ORPHA593":
   {"ontology":"ORPHA",
    "curie":"ORPHA:593",
    "uri":"ORPHA593",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_593"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Dec 18, 2016",
  "scoreJsonSerializedSop5":""},
 "8708":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:11389":
   {"ontology":"HGNC", "curie":"HGNC:11389", "uri":"HGNC11389"}},
  "title":"STK11: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"STK11\",\"Hgnc\":\"11389\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"10\/26\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"10\/26\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1477465200,
  "file":null,
  "dateISO8601":"2016-10-26T00:00:00",
  "entrez_id":"6794",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Oct 26, 2016",
  "scoreJsonSerializedSop5":""},
 "8254":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:11768":
   {"ontology":"HGNC", "curie":"HGNC:11768", "uri":"HGNC11768"}},
  "title":
  "TGFB2 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"TGFB2\",\"Hgnc\":\"11768\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190220\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"},{\"title\":\"A 1-bp duplication in TGFB2 in three family members with a syndromic form of thoracic aortic aneurysm.\",\"author\":\"Leutermann R\",\"pubdate\":\"2014 Jul\",\"source\":\"Eur J Hum Genet\",\"uid\":\"24193348\"}],\"notes\":{\"note\":\"PMID 22772368: 2 probands with p.Pro366His, p.Arg237Trp,  \\r\\nPMID 24193348: 1 bp duplication.\\r\\nAll these cases were associated with syndromic features unlike PMID 22772371\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"3 de novo mutations (2 large deletions; 1 missense (p.Arg330Cys))\\r\\n\"}}},\"VariantIsDeNovo\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"},{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"PMID 22772371: Two large unrelated families segregating Thoracic aortic aneurysm (TAA). They harbored frameshift and nonsense mutations and 2 further  cases in familial TAA cohort p.Glu102* & p.Asn297*\\r\\nPMID 22772368: p.Tyr369Cysfs*26, p.Ala100_Tyr104del, p.Tyr99* variants were found to co-segregate with TAA in the families.\\r\\n\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"},{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"PMID 22772371: 2 large families where loss-of-function mutations (p.Tyr341Cysfs*25 & p. Cys229*) clearly segregate with aortic disease. Family 1: 14 known carriers; 11 had TAA(D); 2 had cerebrovascular disease & 1 apparently unaffected (LOD score 3.3)\\r\\nFamily 2: 6 known carriers; 3 obligate carriers 1 child apparently still unaffected (LOD score 4.4)\\r\\nPMID 22772368: 8 families: All showed complete segregation of aortic phenotype with mutation (penetrance 100%)\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"},{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"PMID  22772368 Binds TGFB receptors; tissue from patients with loss of function variants show up-regulation of TGFB signalling (inc pSMAD, also inc expression of downstream effector genes eg CTGF, collagens \\r\\nPMIDs 22772368 and 22772371:Evidence for reduced circulating TGBF2 ; increased TGFB2 expression in aortic tissue & increased pSMAD.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"}],\"notes\":{\"note\":\"Patient cells: Reduced levels of TGFB2 proprotein in cellular lysates from patient aortas .\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"Heterozygous mouse model (TGFB2+\/-) develops aneurysm by 8 months (2 points) ; TGFB2+\/- FBN+\/C1039G double het displays worse aortic phenotype (1 point)\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"05\/06\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"05\/16\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"05\/16\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nDefinitive for both non syndromic and syndromic forms. Patients primarily present with aortic disease.\"}}",
  "date":1462518000,
  "file":null,
  "dateISO8601":"2016-05-06T00:00:00",
  "entrez_id":"7042",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM190220":
   {"ontology":"OMIM",
    "curie":"OMIM:190220",
    "uri":"OMIM190220",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_190220"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"May 06, 2016",
  "scoreJsonSerializedSop5":""},
 "9868":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"2509":{"ontology":"HGNC", "curie":"HGNC:2509", "uri":"HGNC2509"}},
  "title":"CTNNA1: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CTNNA1\",\"Hgnc\":\"2509\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"04\/24\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"04\/24\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1493017200,
  "file":null,
  "dateISO8601":"2017-04-24T00:00:00",
  "entrez_id":"1495",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Apr 24, 2017",
  "scoreJsonSerializedSop5":""},
 "4845":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Antecubital pterygium syndrome",
  "genes":
  {"HGNC:19093":
   {"ontology":"HGNC", "curie":"HGNC:19093", "uri":"HGNC19093"}},
  "title":"PSD3 Antecubital Pterygium Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"PSD3\",\"Hgnc\":\"19093\",\"OrphaNet\":\"N\/A\",\"Disease\":\"Antecubital pterygium syndrome\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"Only unrelated probands considered.\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"LOD score 1.8\"}}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"4.5\",\"GeneticEvidencePointsTotal\":\"4.5\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06\/03\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11\/24\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1479974400,
  "file":null,
  "dateISO8601":"2016-11-24T00:00:00",
  "entrez_id":"23362",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0008339"},
   "OMIM178200":
   {"ontology":"OMIM",
    "curie":"OMIM:178200",
    "uri":"OMIM178200",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_178200"},
   "ORPHA2987":
   {"ontology":"ORPHA",
    "curie":"ORPHA:2987",
    "uri":"ORPHA2987",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_2987"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Nov 24, 2016",
  "scoreJsonSerializedSop5":""},
 "10151":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:6239":
   {"ontology":"HGNC", "curie":"HGNC:6239", "uri":"HGNC6239"}},
  "title":"KCND3: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"3752",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530657975\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCND3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6239\",\"uri\":\"HGNC6239\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCND3 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.70\",\"Tally\":\"0.7\",\"evidence\":{\"publications\":{\"1530658398631\":{\"title\":\"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.\",\"author\":\"Giudicessi JR\",\"pubdate\":\"2011 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"21349352\"},\"1530658413421\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530658128483\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530658138648\":{\"title\":\"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.\",\"author\":\"Giudicessi JR\",\"pubdate\":\"2011 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"21349352\"},\"1530658147508\":{\"title\":\"Sodium current and potassium transient outward current genes in Brugada syndrome: screening and bioinformatics.\",\"author\":\"Holst AG\",\"pubdate\":\"2012 Mar-Apr\",\"source\":\"Can J Cardiol\",\"uid\":\"22284586\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1.2\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530658198636\":{\"title\":\"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.\",\"author\":\"You T\",\"pubdate\":\"2015 Jul\",\"source\":\"Int J Mol Med\",\"uid\":\"26016905\"},\"1530658211753\":{\"title\":\"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.\",\"author\":\"Giudicessi JR\",\"pubdate\":\"2011 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"21349352\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530658269016\":{\"title\":\"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.\",\"author\":\"You T\",\"pubdate\":\"2015 Jul\",\"source\":\"Int J Mol Med\",\"uid\":\"26016905\"},\"1530658457080\":{\"title\":\"Cloning and expression of the human kv4.3 potassium channel.\",\"author\":\"Dilks D\",\"pubdate\":\"1999 Apr\",\"source\":\"J Neurophysiol\",\"uid\":\"10200233\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1.2\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"3.2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/12\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8505":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Hereditary breast cancer",
  "genes":
  {"HGNC:1925":
   {"ontology":"HGNC", "curie":"HGNC:1925", "uri":"HGNC1925"}},
  "title":"CHEK1: Hereditary breast cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CHEK1\",\"Hgnc\":\"1925\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"10\/12\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"10\/12\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1476255600,
  "file":null,
  "dateISO8601":"2016-10-12T00:00:00",
  "entrez_id":"1111",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016419"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA227535":
   {"ontology":"ORPHA",
    "curie":"ORPHA:227535",
    "uri":"ORPHA227535",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_227535"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Oct 12, 2016",
  "scoreJsonSerializedSop5":""},
 "8256":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:11773":
   {"ontology":"HGNC", "curie":"HGNC:11773", "uri":"HGNC11773"}},
  "title":
  "TGFBR2 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"TGFBR2\",\"Hgnc\":\"11773\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190182\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections.\",\"author\":\"Pannu H\",\"pubdate\":\"2005 Jul 26\",\"source\":\"Circulation\",\"uid\":\"16027248\"},{\"title\":\"Clinical features in a family with an R460H mutation in transforming growth factor beta receptor 2 gene.\",\"author\":\"Law C\",\"pubdate\":\"2006 Dec\",\"source\":\"J Med Genet\",\"uid\":\"16885183\"},{\"title\":\"Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.\",\"author\":\"Stheneur C\",\"pubdate\":\"2008 Nov\",\"source\":\"Hum Mutat\",\"uid\":\"18781618\"},{\"title\":\"Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms.\",\"author\":\"Panesi P\",\"pubdate\":\"2015 Jan\",\"source\":\"Ann Thorac Surg\",\"uid\":\"25555948\"}],\"notes\":{\"note\":\"PMID 16027248: Family TAA035, a large thoracic aortic aneurysm and aortic dissection (TAAD) kindred whose data were used to map the TAAD2 locus to 3p24\\u201325, was found to have the TGFBR2 missense mutation 1378C to T in exon 5, resulting in the substitution of cysteine for an arginine at amino acid 460 (R460C). The same TGFBR2 mutation was present in the proband from another family . The proband presented at 41 years of age with an ascending aneurysm and mitral valve prolapse. The proband was a member of a 4-generation family with autosomal dominant inheritance of TAAD. Points 1.\\r\\nA second mutation was observed in two unrelated probands in two families with some evidence of co-segregation. Points=1 \\r\\nPMID 16885183 TGFBR2 R460H  mutations in 1 large multi-generation family with TAAD and not fulfilling Marfan \/ LDS criteria. Point =0.5\\r\\nPMID 18781618: TGFBR2 mutations in 1 TAAD(p.R537C)  case and 6 \\u201cincomplete MFS\\u201d phenotypes. points=0.25\\r\\n25555948: TGFBR2 mutation (5'untranslated region (c.-59C>T), predicted to be a exonic splice enhancer and shown by qRTPCR in one male with TAAD (abnormal expression in aorta). points=0.25\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.\",\"author\":\"M\\u00e1ty\\u00e1s G\",\"pubdate\":\"2006 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"16791849\"}],\"notes\":{\"note\":\"1 proband with a de novo missense variant (c.1657T>A; pS553T)\"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25.\",\"author\":\"Hasham SN\",\"pubdate\":\"2003 Jul 1\",\"source\":\"Circulation\",\"uid\":\"12821554\"},{\"title\":\"Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections.\",\"author\":\"Pannu H\",\"pubdate\":\"2005 Jul 26\",\"source\":\"Circulation\",\"uid\":\"16027248\"}],\"notes\":{\"note\":\"PMID 12821554: 4-generation family with dominant mode of inheritance of TAAD was studied. Affected status was determined by dilation of the ascending aorta, surgical repair of an aneurysm or dissection, or death as the result of aortic dissection. None of the family members evaluated met the diagnostic criteria for Marfan syndrome. After exclusion of known loci for familial TAAD, a genome-wide scan was carried out to map the defective gene causing the disease in the family. A locus was mapped to a 25-cM region on 3p24-25 with a maximum multipoint logarithm of the odds score of 4.28. Subsequently the causative locus was identified as TGFBR2 mutation (PMID 16027248). Points =5\\r\\n\\r\\nPMID 16027248 A TGFBR2 mutation, 1379G to A, altering arginine\\r\\n460  to a histidine (R460H), was identified in 2 large TAAD kindred. LOD scores were estimated from the combined family. Points =1 \"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Inamoto S\",\"pubdate\":\"2010 Dec 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"20628007\"},{\"title\":\"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.\",\"author\":\"Loeys BL\",\"pubdate\":\"2005 Mar\",\"source\":\"Nat Genet\",\"uid\":\"15731757\"},{\"title\":\"Transforming growth factor beta in cardiovascular development and function.\",\"author\":\"Azhar M\",\"pubdate\":\"2003 Oct\",\"source\":\"Cytokine Growth Factor Rev\",\"uid\":\"12948523\"},{\"title\":\"Postnatal Deletion of the Type II Transforming Growth Factor-\\u03b2 Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.\",\"author\":\"Hu JH\",\"pubdate\":\"2015 Dec\",\"source\":\"Arterioscler Thromb Vasc Biol\",\"uid\":\"26494233\"}],\"notes\":{\"note\":\"Biochemical Function: PMID 20628007: Induction of contractile smooth muscle cell  phenotype - Inamoto et al showed reduced expression of contractile proteins & blunted response to TGFB1. Cells explanted from patients with TGFBR2 mutations + aortic tissue from these patients + transgenic mice with TGFBR2 variants showed reduced expression of VSMC contractile proteins & failed to increase expression in response to TGFB1\\r\\n\\r\\nPMID 15731757: Increased pSMAD2 in patients with TGFBR2 mutations;\\r\\n\\r\\nExpression: PMID 12948523 : Expressed highly in vascular smooth muscle (SMC); expressed in pharyngeal arches during cardiac development. \\r\\n\\r\\nProtein Interaction: PMID 20628007 :  With Col3A1 \\u2013 Inamoto et al showed altered expression in patients with TGFBR2 mutations; PMID 21979435 showed altered expression in SMC-specific TGFBR2 knockouts.\\r\\nWith TGFBR1 \\u2013 Physical interaction to form heterodimer\\r\\nPMID 20628007: With MYH11, ACTA2 \\u2013 showed that SMC-specific TGFBR2 knockouts show reduced expression of these contractile proteins. \\r\\nPMID 26494233: TGFBR3, Tgfb2, Tgfb3, and Smad7 \\u2013 Expression of all increased after post-natal loss of TGFBR2 in mice\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Inamoto S\",\"pubdate\":\"2010 Dec 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"20628007\"},{\"title\":\"Heterozygous TGFBR2 mutations in Marfan syndrome.\",\"author\":\"Mizuguchi T\",\"pubdate\":\"2004 Aug\",\"source\":\"Nat Genet\",\"uid\":\"15235604\"},{\"title\":\"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.\",\"author\":\"Loeys BL\",\"pubdate\":\"2005 Mar\",\"source\":\"Nat Genet\",\"uid\":\"15731757\"}],\"notes\":{\"note\":\"Patient Cells: \\r\\nPMID 20628007: aortic SMCs from patients show decreased expression of SMC contractile proteins\\r\\nPMID 15731757:increased collagen expression, increased nuclear pSMAD2  and increased CTGF in patients with TGFBR2 mutations\\r\\nNon Patient Cells: \\r\\nPMID 15235604:transfected HEK293 cells with disease-causing variant \\u2013 caused loss of TGFB stimulated extracellular matrix producation\\r\\nPMID 20628007: transfected mouse meseenchymal stem cells with TGFBR2 variant constructs \\u2013 these failed to differentiate into an SMC phenotype with TGFB1 stimulation (control cells differentiate).\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Transforming growth factor-\\u03b2 signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis.\",\"author\":\"Jaffe M\",\"pubdate\":\"2012 Jan\",\"source\":\"Arterioscler Thromb Vasc Biol\",\"uid\":\"21979435\"},{\"title\":\"Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.\",\"author\":\"Li W\",\"pubdate\":\"2014 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"24401272\"},{\"title\":\"Postnatal Deletion of the Type II Transforming Growth Factor-\\u03b2 Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.\",\"author\":\"Hu JH\",\"pubdate\":\"2015 Dec\",\"source\":\"Arterioscler Thromb Vasc Biol\",\"uid\":\"26494233\"},{\"title\":\"Angiotensin II-dependent TGF-\\u03b2 signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.\",\"author\":\"Gallo EM\",\"pubdate\":\"2014 Jan\",\"source\":\"J Clin Invest\",\"uid\":\"24355923\"}],\"notes\":{\"note\":\"PMID 24401272: post-natal conditional inactivation of TGFBR2 resulting in aortopathy\\r\\nPMID 26494233: post-natal, SMC-specific knockout of TGFBR2 causes severe aortopathy.\\r\\nPMID 24355923: knock-in mice for Tgfbr2 (G357W) recapitulate aortic phenotype; \\r\\nPMID 21979435: smooth muscle-specific knockout of TGFBR2 in mouse model resulting in abnormal extracellular matrix deposition in aorta; Also differentiationSmooth muscle cell differentiation markers altered in expression in this mouse model.\\r\\n\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"10\",\"GeneticEvidencePointsTotal\":\"10\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01\/25\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"01\/25\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\n\\r\\nConsiderable phenotypic variability humans and mice with different genetic background. Definitive for both LDS and nonsyndromic HTAAD.\"}}",
  "date":1455523200,
  "file":null,
  "dateISO8601":"2016-02-15T00:00:00",
  "entrez_id":"7048",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM190182":
   {"ontology":"OMIM",
    "curie":"OMIM:190182",
    "uri":"OMIM190182",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_190182"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2016",
  "scoreJsonSerializedSop5":""},
 "5658":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Nonsyndromic sensorineural hearing loss",
  "genes":
  {"16513":
   {"ontology":"HGNC", "curie":"HGNC:16513", "uri":"HGNC16513"}},
  "title":"TMC1: Nonsyndromic sensorineural Hearing Loss",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"TMC1\",\"Hgnc\":\"16513\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"600974\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7\/11.\",\"author\":\"Hilgert N\",\"pubdate\":\"2008 Sep\",\"source\":\"Clin Genet\",\"uid\":\"18616530\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"22.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7\/11.\",\"author\":\"Hilgert N\",\"pubdate\":\"2008 Sep\",\"source\":\"Clin Genet\",\"uid\":\"18616530\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2.\",\"author\":\"Maeda R\",\"pubdate\":\"2014 Sep 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"25114259\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Tmc1 is necessary for normal functional maturation and survival of inner and outer hair cells in the mouse cochlea.\",\"author\":\"Marcotti W\",\"pubdate\":\"2006 Aug 1\",\"source\":\"J Physiol\",\"uid\":\"16627570\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"5.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Tmc gene therapy restores auditory function in deaf mice.\",\"author\":\"Askew C\",\"pubdate\":\"2015 Jul 8\",\"source\":\"Sci Transl Med\",\"uid\":\"26157030\"},{\"title\":\"Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes.\",\"author\":\"Kawashima Y\",\"pubdate\":\"2011 Dec\",\"source\":\"J Clin Invest\",\"uid\":\"22105175\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08\/26\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1487145600,
  "file":null,
  "dateISO8601":"2017-02-15T00:00:00",
  "entrez_id":"117531",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0010967"},
   "OMIM600974":
   {"ontology":"OMIM",
    "curie":"OMIM:600974",
    "uri":"OMIM600974",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_600974"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2017",
  "scoreJsonSerializedSop5":""},
 "3211":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Familial or idiopathic dilated cardiomyopathy",
  "genes":
  {"HGNC:11875":
   {"ontology":"HGNC", "curie":"HGNC:11875", "uri":"HGNC11875"}},
  "title":"TMPO  Familial or idiopathic dilated cardiomyopathy",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"TMPO\",\"Hgnc\":\"11875\",\"OrphaNet\":\"\",\"Disease\":\"Dilated Cardiomyopathy\",\"Omim\":\"115200\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.\",\"author\":\"Taylor MR\",\"pubdate\":\"2005 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"16247757\"}],\"notes\":{\"note\":\"c.2068C>T is classified as Benign\/Likely Benign by ClinVar submitters.\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.\",\"author\":\"Taylor MR\",\"pubdate\":\"2005 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"16247757\"}],\"notes\":{\"note\":\"Interaction of mutated protein product with A-type Lamins\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1484319977422\":{\"title\":\"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.\",\"author\":\"Taylor MR\",\"pubdate\":\"2005 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"16247757\"}},\"notes\":{\"note\":\"The only variant that has been reported in association with human disease has been found at high publication frequency in ExAC.\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"0.5\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"10\/07\/16\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"REFUTED\",\"FinalClassificationDate\":\"11\/30\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1480492800,
  "file":null,
  "dateISO8601":"2016-11-30T00:00:00",
  "entrez_id":"7112",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015470"},
   "OMIM613740":
   {"ontology":"OMIM",
    "curie":"OMIM:613740",
    "uri":"OMIM613740",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_613740"},
   "ORPHA154":
   {"ontology":"ORPHA",
    "curie":"ORPHA:154",
    "uri":"ORPHA154",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_154"}},
  "scores":{"3973":{"label":"Contradictory (refuted)"}},
  "dateFormated":"Nov 30, 2016",
  "scoreJsonSerializedSop5":""},
 "8435":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"HGNC:19877":
   {"ontology":"HGNC", "curie":"HGNC:19877", "uri":"HGNC19877"}},
  "title":"GALNT12: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"GALNT12\",\"Hgnc\":\"19877\",\"OrphaNet\":\"ORPHA443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"608812\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.\",\"author\":\"Guda K\",\"pubdate\":\"2009 Aug 4\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19617566\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.\",\"author\":\"Guda K\",\"pubdate\":\"2009 Aug 4\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19617566\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer.\",\"author\":\"Guo JM\",\"pubdate\":\"2004\",\"source\":\"Oncology\",\"uid\":\"15557789\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"4\",\"GeneticEvidencePointsTotal\":\"4\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"09\/13\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"06\/08\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1496905200,
  "file":null,
  "dateISO8601":"2017-06-08T00:00:00",
  "entrez_id":"79695",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0012132"},
   "OMIM608812":
   {"ontology":"OMIM",
    "curie":"OMIM:608812",
    "uri":"OMIM608812",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_608812"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Jun 08, 2017",
  "scoreJsonSerializedSop5":""},
 "8255":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:11772":
   {"ontology":"HGNC", "curie":"HGNC:11772", "uri":"HGNC11772"}},
  "title":
  "TGFBR1 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"TGFBR1\",\"Hgnc\":\"11772\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190181\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"},{\"title\":\"Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations.\",\"author\":\"Tran-Fadulu V\",\"pubdate\":\"2009 Sep\",\"source\":\"J Med Genet\",\"uid\":\"19542084\"},{\"title\":\"Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations.\",\"author\":\"Poninska JK\",\"pubdate\":\"2016 May 4\",\"source\":\"J Transl Med\",\"uid\":\"27146836\"},{\"title\":\"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.\",\"author\":\"M\\u00e1ty\\u00e1s G\",\"pubdate\":\"2006 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"16791849\"},{\"title\":\"Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.\",\"author\":\"Stheneur C\",\"pubdate\":\"2008 Nov\",\"source\":\"Hum Mutat\",\"uid\":\"18781618\"}],\"notes\":{\"note\":\"PMID 26188975 : One proband with segregation evidence with Thoracic aortic aneurysm and dissection (TAAD) . Variant G188V Points for TAAD, isolated : 0.5\\r\\n19542084: Two families had missense mutations in exon 9, TAA009 (R487W) and TAA023 (L486S), and two had mutations in exon 5: TAA336 ( H315R), and TAA339 (G312S).\\r\\n# of probands =4 points: 0.5*3 +1=2.5\\r\\nPMID 27146836: Two probands with isolated TAAD  harboring A202V, Y282H. With some weak segregation data. 0.25*2=0.5\\r\\nPMID 16791849 : Identified one patient with negative family history of TAAD. A heterozygous R487Q mutation was present in a patient with TAAD; variant R487P had been previously reported in a family whose phenotype was identified as Loeys-Dietz syndrome. Points=0.5\\r\\nPMID 18781618: 1\/14 Probands with isolated TAAD harbored  p.Glu218Lys with positive family history. Points=0.25\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.\",\"author\":\"M\\u00e1ty\\u00e1s G\",\"pubdate\":\"2006 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"16791849\"}],\"notes\":{\"note\":\"1 proband with a de novo missense mutation in TGFBR1 c.1460G>A; pR487Q\"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"},{\"title\":\"Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations.\",\"author\":\"Tran-Fadulu V\",\"pubdate\":\"2009 Sep\",\"source\":\"J Med Genet\",\"uid\":\"19542084\"}],\"notes\":{\"note\":\"PMID 26188975: Inferred LOD from pedigree based on 4 segregations. 1.5 points\\r\\nPMID 19542084: Inferred LOD from pedigree based on 6 segregations from family TAA023. 2.5 points\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFBR1 mutations associated with Loeys-Dietz syndrome are inactivating.\",\"author\":\"Cardoso S\",\"pubdate\":\"2012 Jun\",\"source\":\"J Recept Signal Transduct Res\",\"uid\":\"22414221\"}],\"notes\":{\"note\":\"Non patient cells: Receptor function was tested by co-transfection with a luciferase reporter or EGFP-tagged SMAD2 in HEK293 cells. All of the TGFBR1 mutations were found to be inactivating for canonical TGF-\\u03b2 signaling. Points: 2*1(non patient cells)\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events.\",\"author\":\"Yang P\",\"pubdate\":\"2016 Oct 14\",\"source\":\"Sci Rep\",\"uid\":\"27739498\"},{\"title\":\"Angiotensin II-dependent TGF-\\u03b2 signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.\",\"author\":\"Gallo EM\",\"pubdate\":\"2014 Jan\",\"source\":\"J Clin Invest\",\"uid\":\"24355923\"}],\"notes\":{\"note\":\"PMID 27739498: Deletion of smooth muscle cell-specific\\u00a0Tgfbr1\\u00a0in adult mice rapidly causes aneurysmal degeneration of the thoracic aorta + drug induced rescue.  \\r\\nPMID 24355923: mice carrying heterozygous missense LDS mutations, but not mice haploinsufficient for TGF-\\u03b2 receptor alleles, phenotypically recapitulate LDS. Aortic root size and growth in Tgfbr1+\/\\u2013 mice was similar to that observed in wild-type mice, while Tgfbr1 M318R\/+ mice showed enlarged aortas and accelerated aortic root growth.\\r\\nPoints=4\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"10.5\",\"GeneticEvidencePointsTotal\":\"10.5\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10\/12\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10\/18\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nDefinitive for both syndromic and non-syndromic TAAD.\"}}",
  "date":1476255600,
  "file":null,
  "dateISO8601":"2016-10-12T00:00:00",
  "entrez_id":"7046",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM190181":
   {"ontology":"OMIM",
    "curie":"OMIM:190181",
    "uri":"OMIM190181",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_190181"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Oct 12, 2016",
  "scoreJsonSerializedSop5":""},
 "10150":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:16882":
   {"ontology":"HGNC", "curie":"HGNC:16882", "uri":"HGNC16882"}},
  "title":"HCN4: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"10021",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530657570\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"HCN4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:16882\",\"uri\":\"HGNC16882\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"HCN4 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.90\",\"Tally\":\"1.9\",\"evidence\":{\"publications\":{\"1530657656772\":{\"title\":\"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.\",\"author\":\"Ueda K\",\"pubdate\":\"2004 Jun 25\",\"source\":\"J Biol Chem\",\"uid\":\"15123648\"},\"1530657674185\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530657684290\":{\"title\":\"Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.\",\"author\":\"Biel S\",\"pubdate\":\"2016 Oct\",\"source\":\"Pflugers Arch\",\"uid\":\"27553229\"},\"1530657714168\":{\"title\":\"Role of HCN4 channel in preventing ventricular arrhythmia.\",\"author\":\"Ueda K\",\"pubdate\":\"2009 Feb\",\"source\":\"J Hum Genet\",\"uid\":\"19165230\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1.9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530657738038\":{\"title\":\"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.\",\"author\":\"Ueda K\",\"pubdate\":\"2004 Jun 25\",\"source\":\"J Biol Chem\",\"uid\":\"15123648\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530657746847\":{\"title\":\"Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.\",\"author\":\"Biel S\",\"pubdate\":\"2016 Oct\",\"source\":\"Pflugers Arch\",\"uid\":\"27553229\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1.9\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"2.9\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06\/25\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "10155":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:6269":
   {"ontology":"HGNC", "curie":"HGNC:6269", "uri":"HGNC6269"}},
  "title":"KCNJ8: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"3764",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530660569\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNJ8\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6269\",\"uri\":\"HGNC6269\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNJ8 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.25\",\"Tally\":\"0.25\",\"evidence\":{\"publications\":{\"1530660630050\":{\"title\":\"Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.\",\"author\":\"Medeiros-Domingo A\",\"pubdate\":\"2010 Oct\",\"source\":\"Heart Rhythm\",\"uid\":\"20558321\"},\"1530660641169\":{\"title\":\"Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8.\",\"author\":\"Barajas-Mart\\u00ednez H\",\"pubdate\":\"2012 Apr\",\"source\":\"Heart Rhythm\",\"uid\":\"22056721\"},\"1530660666040\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530660854993\":{\"title\":\"Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8\/KATP channel.\",\"author\":\"Ha\\u00efssaguerre M\",\"pubdate\":\"2009 Jan\",\"source\":\"J Cardiovasc Electrophysiol\",\"uid\":\"19120683\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530660716256\":{\"title\":\"Role of ATP-sensitive K+ channels in cardiac arrhythmias.\",\"author\":\"Nakaya H\",\"pubdate\":\"2014 May\",\"source\":\"J Cardiovasc Pharmacol Ther\",\"uid\":\"24367007\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530660805195\":{\"title\":\"Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.\",\"author\":\"Miki T\",\"pubdate\":\"2002 May\",\"source\":\"Nat Med\",\"uid\":\"11984590\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.25\",\"ExperimentalEvidenceTotal\":\"0.5\",\"EvidencePointsTotal\":\"0.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01\/19\/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8404":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Nonsyndromic sensorineural hearing loss",
  "genes":
  {"9679":{"ontology":"HGNC", "curie":"HGNC:9679", "uri":"HGNC9679"}},
  "title":"PTPRQ: Nonsyndromic sensorineural hearing loss",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"PTPRQ\",\"Hgnc\":\"9679\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"603317\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.5\",\"tally\":\"5.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.\",\"author\":\"Schraders M\",\"pubdate\":\"2010 Apr 9\",\"source\":\"Am J Hum Genet\",\"uid\":\"20346435\"},{\"title\":\"Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.\",\"author\":\"Shahin H\",\"pubdate\":\"2010 Sep\",\"source\":\"J Med Genet\",\"uid\":\"20472657\"},{\"title\":\"Identification of Two Novel Compound Heterozygous PTPRQ Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family.\",\"author\":\"Gao X\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"25919374\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"8.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.\",\"author\":\"Schraders M\",\"pubdate\":\"2010 Apr 9\",\"source\":\"Am J Hum Genet\",\"uid\":\"20346435\"},{\"title\":\"Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.\",\"author\":\"Shahin H\",\"pubdate\":\"2010 Sep\",\"source\":\"J Med Genet\",\"uid\":\"20472657\"},{\"title\":\"Identification of Two Novel Compound Heterozygous PTPRQ Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family.\",\"author\":\"Gao X\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"25919374\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles.\",\"author\":\"Goodyear RJ\",\"pubdate\":\"2003 Oct 8\",\"source\":\"J Neurosci\",\"uid\":\"14534255\"},{\"title\":\"Dynamic compartmentalization of protein tyrosine phosphatase receptor Q at the proximal end of stereocilia: implication of myosin VI-based transport.\",\"author\":\"Sakaguchi H\",\"pubdate\":\"2008 Jul\",\"source\":\"Cell Motil Cytoskeleton\",\"uid\":\"18412156\"},{\"title\":\"CLIC5 stabilizes membrane-actin filament linkages at the base of hair cell stereocilia in a molecular complex with radixin, taperin, and myosin VI.\",\"author\":\"Salles FT\",\"pubdate\":\"2014 Jan\",\"source\":\"Cytoskeleton (Hoboken)\",\"uid\":\"24285636\"},{\"title\":\"A reduction in Ptprq associated with specific features of the deafness phenotype of the miR-96 mutant mouse diminuendo.\",\"author\":\"Chen J\",\"pubdate\":\"2014 Mar\",\"source\":\"Eur J Neurosci\",\"uid\":\"24446963\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles.\",\"author\":\"Goodyear RJ\",\"pubdate\":\"2003 Oct 8\",\"source\":\"J Neurosci\",\"uid\":\"14534255\"},{\"title\":\"Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ.\",\"author\":\"Goodyear RJ\",\"pubdate\":\"2012 Feb 22\",\"source\":\"J Neurosci\",\"uid\":\"22357859\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10\/25\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/23\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1487836800,
  "file":null,
  "dateISO8601":"2017-02-23T00:00:00",
  "entrez_id":"374462",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019588"},
   "OMIM603317":
   {"ontology":"OMIM",
    "curie":"OMIM:603317",
    "uri":"OMIM603317",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_603317"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 23, 2017",
  "scoreJsonSerializedSop5":""},
 "8400":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 3",
  "genes":
  {"12605":
   {"ontology":"HGNC", "curie":"HGNC:12605", "uri":"HGNC12605"}},
  "title":"CLRN1: Usher syndrome type 3",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CLRN1\",\"Hgnc\":\"12605\",\"OrphaNet\":\"231183\",\"Disease\":\"Usher syndrome type 3\",\"Omim\":\"606397\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"2.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3.\",\"author\":\"Joensuu T\",\"pubdate\":\"2001 Oct\",\"source\":\"Am J Hum Genet\",\"uid\":\"11524702\"},{\"title\":\"Strategies for genetic study of hearing loss in the Brazilian northeastern region.\",\"author\":\"Melo US\",\"pubdate\":\"2014\",\"source\":\"Int J Mol Epidemiol Genet\",\"uid\":\"24596593\"},{\"title\":\"Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study.\",\"author\":\"Le Quesne Stabej P\",\"pubdate\":\"2012 Jan\",\"source\":\"J Med Genet\",\"uid\":\"22135276\"},{\"title\":\"A novel 5-bp deletion in Clarin 1 in a family with Usher syndrome.\",\"author\":\"Akoury E\",\"pubdate\":\"2011 Nov\",\"source\":\"Ophthalmic Genet\",\"uid\":\"21675857\"},{\"title\":\"Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.\",\"author\":\"Isosomppi J\",\"pubdate\":\"2009 Sep 8\",\"source\":\"Mol Vis\",\"uid\":\"19753315\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3.\",\"author\":\"Joensuu T\",\"pubdate\":\"2001 Oct\",\"source\":\"Am J Hum Genet\",\"uid\":\"11524702\"},{\"title\":\"Strategies for genetic study of hearing loss in the Brazilian northeastern region.\",\"author\":\"Melo US\",\"pubdate\":\"2014\",\"source\":\"Int J Mol Epidemiol Genet\",\"uid\":\"24596593\"},{\"title\":\"A novel 5-bp deletion in Clarin 1 in a family with Usher syndrome.\",\"author\":\"Akoury E\",\"pubdate\":\"2011 Nov\",\"source\":\"Ophthalmic Genet\",\"uid\":\"21675857\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Role for a novel Usher protein complex in hair cell synaptic maturation.\",\"author\":\"Zallocchi M\",\"pubdate\":\"2012\",\"source\":\"PLoS One\",\"uid\":\"22363448\"},{\"title\":\"Localization and expression of clarin-1, the Clrn1 gene product, in auditory hair cells and photoreceptors.\",\"author\":\"Zallocchi M\",\"pubdate\":\"2009 Sep\",\"source\":\"Hear Res\",\"uid\":\"19539019\"},{\"title\":\"The cone-dominant retina and the inner ear of zebrafish express the ortholog of CLRN1, the causative gene of human Usher syndrome type 3A.\",\"author\":\"Phillips JB\",\"pubdate\":\"2013 Dec\",\"source\":\"Gene Expr Patterns\",\"uid\":\"24045267\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.\",\"author\":\"Isosomppi J\",\"pubdate\":\"2009 Sep 8\",\"source\":\"Mol Vis\",\"uid\":\"19753315\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"A small molecule mitigates hearing loss in a mouse model of Usher syndrome III.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2016 Jun\",\"source\":\"Nat Chem Biol\",\"uid\":\"27110679\"},{\"title\":\"Impairment of Vision in a Mouse Model of Usher Syndrome Type III.\",\"author\":\"Tian G\",\"pubdate\":\"2016 Mar\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"26943149\"},{\"title\":\"The mechanosensory structure of the hair cell requires clarin-1, a protein encoded by Usher syndrome III causative gene.\",\"author\":\"Geng R\",\"pubdate\":\"2012 Jul 11\",\"source\":\"J Neurosci\",\"uid\":\"22787034\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09\/30\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03\/02\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hereditary Hearing Loss Working Group\"}}",
  "date":1488441600,
  "file":null,
  "dateISO8601":"2017-03-02T00:00:00",
  "entrez_id":"7401",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016485"},
   "OMIM606397":
   {"ontology":"OMIM",
    "curie":"OMIM:606397",
    "uri":"OMIM606397",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_606397"},
   "ORPHA231183":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231183",
    "uri":"ORPHA231183",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231183"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Mar 02, 2017",
  "scoreJsonSerializedSop5":""},
 "10149":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:28956":
   {"ontology":"HGNC", "curie":"HGNC:28956", "uri":"HGNC28956"}},
  "title":"GPD1L: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"23171",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530656792\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"GPD1L\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:28956\",\"uri\":\"HGNC28956\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"GPD1L Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.60\",\"Tally\":\"0.6\",\"evidence\":{\"publications\":{\"1530656885014\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"},\"1530656906475\":{\"title\":\"Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in Japanese patients with Brugada syndrome.\",\"author\":\"Makiyama T\",\"pubdate\":\"2008 Oct\",\"source\":\"Circ J\",\"uid\":\"18762705\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"6.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1530657310489\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3.6\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530656965640\":{\"title\":\"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.\",\"author\":\"Valdivia CR\",\"pubdate\":\"2009 Oct\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19666841\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.75\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530656998666\":{\"title\":\"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.\",\"author\":\"Valdivia CR\",\"pubdate\":\"2009 Oct\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19666841\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.75\",\"evidence\":{\"publications\":{\"1530656934008\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530656949651\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"},\"1530657009707\":{\"title\":\"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.\",\"author\":\"Valdivia CR\",\"pubdate\":\"2009 Oct\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19666841\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.75\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3.6\",\"ExperimentalEvidenceTotal\":\"2.75\",\"EvidencePointsTotal\":\"6.35\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05\/09\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "3216":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":
  "Immunodeficiency due to an early component of complement deficiency",
  "genes":
  {"HGNC:1242":
   {"ontology":"HGNC", "curie":"HGNC:1242", "uri":"HGNC1242"}},
  "title":
  "C1QB  Immunodeficiency due to an early component of complement deficiency",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"C1QB\",\"Hgnc\":\"1242\",\"OrphaNet\":\"ORPHA169147\",\"Disease\":\"Immunodeficiency due to an early component of complement deficiency\",\"Omim\":\"613652\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"2.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects.\",\"author\":\"Petry F\",\"pubdate\":\"1997 Dec\",\"source\":\"Immunopharmacology\",\"uid\":\"9476130\"},{\"title\":\"C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.\",\"author\":\"Marquart HV\",\"pubdate\":\"2007 Jul\",\"source\":\"Clin Immunol\",\"uid\":\"17513176\"},{\"title\":\"A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.\",\"author\":\"McAdam RA\",\"pubdate\":\"1988\",\"source\":\"Immunogenetics\",\"uid\":\"2894352\"},{\"title\":\"Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy.\",\"author\":\"Troedson C\",\"pubdate\":\"2013 May\",\"source\":\"Lupus\",\"uid\":\"23651859\"},{\"title\":\"The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.\",\"author\":\"Higuchi Y\",\"pubdate\":\"2013 Oct 28\",\"source\":\"Pediatr Rheumatol Online J\",\"uid\":\"24160257\"},{\"title\":\"Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.\",\"author\":\"van Schaarenburg RA\",\"pubdate\":\"2015 Mar\",\"source\":\"Immunobiology\",\"uid\":\"25454803\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.5\",\"tally\":\"3.5\",\"pmid\":{\"publications\":[{\"title\":\"C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.\",\"author\":\"Marquart HV\",\"pubdate\":\"2007 Jul\",\"source\":\"Clin Immunol\",\"uid\":\"17513176\"},{\"title\":\"The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.\",\"author\":\"Higuchi Y\",\"pubdate\":\"2013 Oct 28\",\"source\":\"Pediatr Rheumatol Online J\",\"uid\":\"24160257\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.\",\"author\":\"van Schaarenburg RA\",\"pubdate\":\"2015 Mar\",\"source\":\"Immunobiology\",\"uid\":\"25454803\"},{\"title\":\"The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.\",\"author\":\"Higuchi Y\",\"pubdate\":\"2013 Oct 28\",\"source\":\"Pediatr Rheumatol Online J\",\"uid\":\"24160257\"},{\"title\":\"A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.\",\"author\":\"McAdam RA\",\"pubdate\":\"1988\",\"source\":\"Immunogenetics\",\"uid\":\"2894352\"},{\"title\":\"Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects.\",\"author\":\"Petry F\",\"pubdate\":\"1997 Dec\",\"source\":\"Immunopharmacology\",\"uid\":\"9476130\"},{\"title\":\"C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.\",\"author\":\"Marquart HV\",\"pubdate\":\"2007 Jul\",\"source\":\"Clin Immunol\",\"uid\":\"17513176\"},{\"title\":\"Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.\",\"author\":\"van Schaarenburg RA\",\"pubdate\":\"2015 Mar\",\"source\":\"Immunobiology\",\"uid\":\"25454803\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.\",\"author\":\"McAdam RA\",\"pubdate\":\"1988\",\"source\":\"Immunogenetics\",\"uid\":\"2894352\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"C1q regulatory region polymorphism down-regulating murine c1q protein levels with linkage to lupus nephritis.\",\"author\":\"Miura-Shimura Y\",\"pubdate\":\"2002 Aug 1\",\"source\":\"J Immunol\",\"uid\":\"12133956\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06\/13\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01\/09\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1483948800,
  "file":null,
  "dateISO8601":"2017-01-09T00:00:00",
  "entrez_id":"713",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0013343"},
   "OMIM613652":
   {"ontology":"OMIM",
    "curie":"OMIM:613652",
    "uri":"OMIM613652",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_613652"},
   "ORPHA169147":
   {"ontology":"ORPHA",
    "curie":"ORPHA:169147",
    "uri":"ORPHA169147",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_169147"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jan 09, 2017",
  "scoreJsonSerializedSop5":""},
 "3220":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Renal or urinary tract malformation (CAKUT)",
  "genes":
  {"HGNC:1916":
   {"ontology":"HGNC", "curie":"HGNC:1916", "uri":"HGNC1916"}},
  "title":"CHD1L  Renal or urinary tract malformation (CAKUT)",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CHD1L\",\"Hgnc\":\"1916\",\"OrphaNet\":\"ORPHA93545\",\"Disease\":\"Renal or urinary tract malformation (CAKUT)\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.5\",\"tally\":\"2.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract.\",\"author\":\"Hwang DY\",\"pubdate\":\"2014 Jun\",\"source\":\"Kidney Int\",\"uid\":\"24429398\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT).\",\"author\":\"Brockschmidt A\",\"pubdate\":\"2012 Jun\",\"source\":\"Nephrol Dial Transplant\",\"uid\":\"22146311\"}],\"notes\":{\"note\":\"\"}}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"3.5\",\"GeneticEvidencePointsTotal\":\"2.5\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05\/25\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11\/18\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1479456000,
  "file":null,
  "dateISO8601":"2016-11-18T00:00:00",
  "entrez_id":"9557",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019719"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA93545":
   {"ontology":"ORPHA",
    "curie":"ORPHA:93545",
    "uri":"ORPHA93545",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_93545"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Nov 18, 2016",
  "scoreJsonSerializedSop5":""},
 "10159":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:10589":
   {"ontology":"HGNC", "curie":"HGNC:10589", "uri":"HGNC10589"}},
  "title":"SCN2B: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"6327",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530663649\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN2B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10589\",\"uri\":\"HGNC10589\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN2B Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1530663719285\":{\"title\":\"A missense mutation in the sodium channel \\u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.\",\"author\":\"Riur\\u00f3 H\",\"pubdate\":\"2013 Jul\",\"source\":\"Hum Mutat\",\"uid\":\"23559163\"},\"1530663731135\":{\"title\":\"Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.\",\"author\":\"Selga E\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26173111\"},\"1530663748696\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.25\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530663987924\":{\"title\":\"Mutations in sodium channel \\u03b21- and \\u03b22-subunits associated with atrial fibrillation.\",\"author\":\"Watanabe H\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19808477\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530663766775\":{\"title\":\"A missense mutation in the sodium channel \\u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.\",\"author\":\"Riur\\u00f3 H\",\"pubdate\":\"2013 Jul\",\"source\":\"Hum Mutat\",\"uid\":\"23559163\"},\"1530663794332\":{\"title\":\"Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias.\",\"author\":\"Bao Y\",\"pubdate\":\"2016 Dec\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"27932425\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530663780246\":{\"title\":\"Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias.\",\"author\":\"Bao Y\",\"pubdate\":\"2016 Dec\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"27932425\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"2.25\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/05\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "10160":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:20665":
   {"ontology":"HGNC", "curie":"HGNC:20665", "uri":"HGNC20665"}},
  "title":"SCN3B: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"55800",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011001"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530664150\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN3B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:20665\",\"uri\":\"HGNC20665\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN3B Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530664228465\":{\"title\":\"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.\",\"author\":\"Hu D\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"20031595\"},\"1530664245152\":{\"title\":\"Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5.\",\"author\":\"Ishikawa T\",\"pubdate\":\"2013\",\"source\":\"Circ J\",\"uid\":\"23257389\"},\"1530664282182\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"},\"1530664293434\":{\"title\":\"Is sudden unexplained nocturnal death syndrome in Southern China a cardiac sodium channel dysfunction disorder?\",\"author\":\"Liu C\",\"pubdate\":\"2014 Mar\",\"source\":\"Forensic Sci Int\",\"uid\":\"24529773\"},\"1530664317455\":{\"title\":\"Sudden infant death syndrome-associated mutations in the sodium channel beta subunits.\",\"author\":\"Tan BH\",\"pubdate\":\"2010 Jun\",\"source\":\"Heart Rhythm\",\"uid\":\"20226894\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530664395978\":{\"title\":\"The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart.\",\"author\":\"Fahmi AI\",\"pubdate\":\"2001 Dec 15\",\"source\":\"J Physiol\",\"uid\":\"11744748\"},\"1530664411241\":{\"title\":\"Modulation of Na(v)1.5 by beta1-- and beta3-subunit co-expression in mammalian cells.\",\"author\":\"Ko SH\",\"pubdate\":\"2005 Jan\",\"source\":\"Pflugers Arch\",\"uid\":\"15455233\"},\"1530664469708\":{\"title\":\"Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart.\",\"author\":\"Maier SK\",\"pubdate\":\"2004 Mar 23\",\"source\":\"Circulation\",\"uid\":\"15007009\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530664427479\":{\"title\":\"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.\",\"author\":\"Hu D\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"20031595\"},\"1530664439305\":{\"title\":\"Mutations in sodium channel \\u03b2-subunit SCN3B are associated with early-onset lone atrial fibrillation.\",\"author\":\"Olesen MS\",\"pubdate\":\"2011 Mar 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"21051419\"},\"1530664455290\":{\"title\":\"Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties.\",\"author\":\"Hakim P\",\"pubdate\":\"2008 Oct-Nov\",\"source\":\"Prog Biophys Mol Biol\",\"uid\":\"19351516\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530664344778\":{\"title\":\"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.\",\"author\":\"Hu D\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"20031595\"},\"1530664357861\":{\"title\":\"Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5.\",\"author\":\"Ishikawa T\",\"pubdate\":\"2013\",\"source\":\"Circ J\",\"uid\":\"23257389\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530664481815\":{\"title\":\"Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties.\",\"author\":\"Hakim P\",\"pubdate\":\"2008 Oct-Nov\",\"source\":\"Prog Biophys Mol Biol\",\"uid\":\"19351516\"},\"1530664621382\":{\"title\":\"Embryonic type Na<sup>+<\/sup> channel \\u03b2-subunit, SCN3B masks the disease phenotype of Brugada syndrome.\",\"author\":\"Okata S\",\"pubdate\":\"2016 Sep 28\",\"source\":\"Sci Rep\",\"uid\":\"27677334\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"3\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"12\/01\/2016\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "10165":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:10593":
   {"ontology":"HGNC", "curie":"HGNC:10593", "uri":"HGNC10593"}},
  "title":"SCN5A: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"6331",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530666845\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN5A\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10593\",\"uri\":\"HGNC10593\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN5A Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"evidence\":{\"publications\":{\"1530667111613\":{\"title\":\"Novel mutations in domain I of SCN5A cause Brugada syndrome.\",\"author\":\"Vatta M\",\"pubdate\":\"2002 Apr\",\"source\":\"Mol Genet Metab\",\"uid\":\"12051963\"},\"1530667147506\":{\"title\":\"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.\",\"author\":\"Chen Q\",\"pubdate\":\"1998 Mar 19\",\"source\":\"Nature\",\"uid\":\"9521325\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.50\",\"Tally\":\"2.5\",\"evidence\":{\"publications\":{\"1530666938420\":{\"title\":\"Novel mutations in domain I of SCN5A cause Brugada syndrome.\",\"author\":\"Vatta M\",\"pubdate\":\"2002 Apr\",\"source\":\"Mol Genet Metab\",\"uid\":\"12051963\"},\"1530666957480\":{\"title\":\"Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.\",\"author\":\"Desch\\u00eanes I\",\"pubdate\":\"2000 Apr\",\"source\":\"Cardiovasc Res\",\"uid\":\"10727653\"},\"1530666980611\":{\"title\":\"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.\",\"author\":\"Chen Q\",\"pubdate\":\"1998 Mar 19\",\"source\":\"Nature\",\"uid\":\"9521325\"},\"1530667408586\":{\"title\":\"A single Na(+) channel mutation causing both long-QT and Brugada syndromes.\",\"author\":\"Bezzina C\",\"pubdate\":\"1999 Dec 3-17\",\"source\":\"Circ Res\",\"uid\":\"10590249\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1530667198963\":{\"title\":\"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.\",\"author\":\"Chen Q\",\"pubdate\":\"1998 Mar 19\",\"source\":\"Nature\",\"uid\":\"9521325\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"5.5\",\"AggregateVariantAnalysis\":{\"Value\":\"5.50\",\"evidence\":{\"publications\":{\"1530667017568\":{\"title\":\"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.\",\"author\":\"Kapplinger JD\",\"pubdate\":\"2010 Jan\",\"source\":\"Heart Rhythm\",\"uid\":\"20129283\"},\"1530667038737\":{\"title\":\"Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.\",\"author\":\"Schulze-Bahr E\",\"pubdate\":\"2003 Jun\",\"source\":\"Hum Mutat\",\"uid\":\"14961552\"}},\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530667071394\":{\"title\":\"Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.\",\"author\":\"Liang P\",\"pubdate\":\"2016 Nov 8\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27810048\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530667349033\":{\"title\":\"Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.\",\"author\":\"Rook MB\",\"pubdate\":\"1999 Dec\",\"source\":\"Cardiovasc Res\",\"uid\":\"10690282\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530667251596\":{\"title\":\"Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.\",\"author\":\"Liang P\",\"pubdate\":\"2016 Nov 8\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27810048\"}},\"notes\":{\"note\":\"\"}}}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"13\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07\/13\/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "9865":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"12831":
   {"ontology":"HGNC", "curie":"HGNC:12831", "uri":"HGNC12831"}},
  "title":"XRCC4: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"XRCC4\",\"Hgnc\":\"12831\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"1.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05\/08\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"05\/08\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1494226800,
  "file":null,
  "dateISO8601":"2017-05-08T00:00:00",
  "entrez_id":"7518",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"May 08, 2017",
  "scoreJsonSerializedSop5":""},
 "9866":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"11100":
   {"ontology":"HGNC", "curie":"HGNC:11100", "uri":"HGNC11100"}},
  "title":"SMARCA4: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"SMARCA4\",\"Hgnc\":\"11100\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.1\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A.\",\"author\":\"Lin S\",\"pubdate\":\"2016 Dec 27\",\"source\":\"Oncotarget\",\"uid\":\"27852072\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"0.6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05\/08\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"05\/08\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1494226800,
  "file":null,
  "dateISO8601":"2017-05-08T00:00:00",
  "entrez_id":"6597",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"May 08, 2017",
  "scoreJsonSerializedSop5":""},
 "10163":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:16643":
   {"ontology":"HGNC", "curie":"HGNC:16643", "uri":"HGNC16643"}},
  "title":"SLMAP: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"7871",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530665794\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SLMAP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:16643\",\"uri\":\"HGNC16643\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SLMAP Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.25\",\"Tally\":\"0.25\",\"evidence\":{\"publications\":{\"1530665990552\":{\"title\":\"A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5.\",\"author\":\"Ishikawa T\",\"pubdate\":\"2012 Dec\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"23064965\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530666152564\":{\"title\":\"Molecular properties of cardiac tail-anchored membrane protein SLMAP are consistent with structural role in arrangement of excitation-contraction coupling apparatus.\",\"author\":\"Guzzo RM\",\"pubdate\":\"2005 Apr\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"15591093\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530666112007\":{\"title\":\"Molecular cloning, expression, and chromosomal assignment of sarcolemmal-associated proteins. A family of acidic amphipathic alpha-helical proteins associated with the membrane.\",\"author\":\"Wigle JT\",\"pubdate\":\"1997 Dec 19\",\"source\":\"J Biol Chem\",\"uid\":\"9405447\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530666192249\":{\"title\":\"Tail-anchored membrane protein SLMAP is a novel regulator of cardiac function at the sarcoplasmic reticulum.\",\"author\":\"Nader M\",\"pubdate\":\"2012 Mar 1\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"22180652\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.25\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"1.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/11\/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8266":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:11769":
   {"ontology":"HGNC", "curie":"HGNC:11769", "uri":"HGNC11769"}},
  "title":
  "TGFB3 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"TGFB3\",\"Hgnc\":\"11769\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190230\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in a TGF-\\u03b2 ligand, TGFB3, cause syndromic aortic aneurysms and dissections.\",\"author\":\"Bertoli-Avella AM\",\"pubdate\":\"2015 Apr 7\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"25835445\"}],\"notes\":{\"note\":\"In 120 TAAD patients, a targeted analysis of thoracic aortic aneurysm and aortic dissection (TAAD) candidate genes after whole-exome sequencing was performed. This revealed 3 heterozygous TGFB3 mutations in unrelated individuals. However in absence of data other than in silico prediction the number of points assigned for non-syndromic TAAD =1.  \"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome.\",\"author\":\"Rienhoff HY Jr\",\"pubdate\":\"2013 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"23824657\"},{\"title\":\"Mutations in a TGF-\\u03b2 ligand, TGFB3, cause syndromic aortic aneurysms and dissections.\",\"author\":\"Bertoli-Avella AM\",\"pubdate\":\"2015 Apr 7\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"25835445\"},{\"title\":\"Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.\",\"author\":\"Nataatmadja M\",\"pubdate\":\"2006 Jul 4\",\"source\":\"Circulation\",\"uid\":\"16820603\"}],\"notes\":{\"note\":\"Biochemical function:\\r\\n23824657: TGFB3-dependent pSMAD2 and pERK1\/2 signals are significantly diminished with increasing amounts of the mutant RNA (G1226A) relative to wild-type in Xenopus embryos.\\r\\nPMID 25835445: Microscopic examination of the dissected aortic wall from patient, obtained at the time of surgery , showed elastic fiber fragmentation with higher collagen and proteoglycan deposition.\\r\\nAlso evidence of paradoxically enhanced TGF-\\u03b2 signaling in the aortic wall of a TGFB3 mutant patient (3-III:1), as shown by increased pSMAD2 (canonical TGF-\\u03b2 signaling), pERK (noncanonical TGF-\\u03b2 signaling), and elevated TGFB1 messenger RNA.\\r\\nExpression:\\r\\nPMID 16820603: Increased expression of each of the 3 human TGF-\\u03b2 isoforms in aneurysm tissue and in cultured vascular smooth muscle cells (VSMC) and fibroblasts derived from aorta and skin of MFS patients, compared with controls; did not reach significance for TGF\\u03b22 and \\u03b23 in aneurysm tissue or for TGF\\u03b23 in cultured VSMCs .\\r\\nWestern blot studies showed 3-fold increase in the expression of TGF\\u03b21, \\u03b22, and \\u03b23 in SF and VSMC derived from Marfan syndrome patients in comparison to controls, consistent with the immunohistochemical findings in aortic tissue and cultured cells.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07\/11\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"07\/11\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nLimited clinical evidence for association with non syndromic TAAD. Convincing evidence for association with syndromic aortic aneurysms as shown in PMID 25835445.\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"7043",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM190230":
   {"ontology":"OMIM",
    "curie":"OMIM:190230",
    "uri":"OMIM190230",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_190230"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "8707":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:12829":
   {"ontology":"HGNC", "curie":"HGNC:12829", "uri":"HGNC12829"}},
  "title":"XRCC2: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"XRCC2\",\"Hgnc\":\"12829\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"04\/26\/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"04\/26\/2017\",\"FinalClassificationNotes\":\"\"}}",
  "date":1493190000,
  "file":null,
  "dateISO8601":"2017-04-26T00:00:00",
  "entrez_id":"7516",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Apr 26, 2017",
  "scoreJsonSerializedSop5":""},
 "4842":
 {"affiliation":{"id":"10026", "name":"General Gene Curation"},
  "label":"Achromatopsia",
  "genes":
  {"HGNC:791":
   {"ontology":"HGNC", "curie":"HGNC:791", "uri":"HGNC791"}},
  "title":"ATF6 Achromatopsia",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"ATF6\",\"Hgnc\":\"791\",\"OrphaNet\":\"ORPHA49382\",\"Disease\":\"Achromatopsia\",\"Omim\":\"616517\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"3.5\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"},{\"title\":\"Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.\",\"author\":\"Kohl S\",\"pubdate\":\"2015 Jul\",\"source\":\"Nat Genet\",\"uid\":\"26029869\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"9.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"},{\"title\":\"Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.\",\"author\":\"Kohl S\",\"pubdate\":\"2015 Jul\",\"source\":\"Nat Genet\",\"uid\":\"26029869\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.\",\"author\":\"Kohl S\",\"pubdate\":\"2015 Jul\",\"source\":\"Nat Genet\",\"uid\":\"26029869\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"14\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"06\/01\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"11\/16\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1479283200,
  "file":null,
  "dateISO8601":"2016-11-16T00:00:00",
  "entrez_id":"22926",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018852"},
   "OMIM616517":
   {"ontology":"OMIM",
    "curie":"OMIM:616517",
    "uri":"OMIM616517",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_616517"},
   "ORPHA49382":
   {"ontology":"ORPHA",
    "curie":"ORPHA:49382",
    "uri":"ORPHA49382",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_49382"}},
  "scores":{"3978":{"label":"Strong"}},
  "dateFormated":"Nov 16, 2016",
  "scoreJsonSerializedSop5":""},
 "8431":
 {"affiliation":{"id":"10043", "name":"Colon Cancer"},
  "label":"Colorectal cancer Susceptibility",
  "genes":
  {"HGNC:3401":
   {"ontology":"HGNC", "curie":"HGNC:3401", "uri":"HGNC3401"}},
  "title":"EPHX1: Colorectal cancer Susceptibility",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"EPHX1\",\"Hgnc\":\"3401\",\"OrphaNet\":\"ORPHA:443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.1\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.\",\"author\":\"Hassett C\",\"pubdate\":\"1994 Mar\",\"source\":\"Hum Mol Genet\",\"uid\":\"7516776\"},{\"title\":\"Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours.\",\"author\":\"Coller JK\",\"pubdate\":\"2001 Jun\",\"source\":\"Histochem J\",\"uid\":\"11758809\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"1.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11\/08\/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11\/08\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1478592000,
  "file":null,
  "dateISO8601":"2016-11-08T00:00:00",
  "entrez_id":"2052",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0018630"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA443909":
   {"ontology":"ORPHA",
    "curie":"ORPHA:443909",
    "uri":"ORPHA443909",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_443909"}},
  "scores":{"3974":{"label":"Limited"}},
  "dateFormated":"Nov 08, 2016",
  "scoreJsonSerializedSop5":""},
 "5660":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Usher syndrome type 1",
  "genes":
  {"16356":
   {"ontology":"HGNC", "curie":"HGNC:16356", "uri":"HGNC16356"}},
  "title":"USH1G Usher syndrome type 1",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"USH1G\",\"Hgnc\":\"16356\",\"OrphaNet\":\"ORPHA231169\",\"Disease\":\"Usher Syndrome, Type 1\",\"Omim\":\"606943\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25.\",\"author\":\"Mustapha M\",\"pubdate\":\"2002 Apr\",\"source\":\"Hum Genet\",\"uid\":\"11941484\"},{\"title\":\"Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.\",\"author\":\"Weil D\",\"pubdate\":\"2003 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12588794\"},{\"title\":\"Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome.\",\"author\":\"Abdi S\",\"pubdate\":\"2016 Sep 1\",\"source\":\"PLoS One\",\"uid\":\"27583663\"},{\"title\":\"Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.\",\"author\":\"Riahi Z\",\"pubdate\":\"2015 Mar 23\",\"source\":\"PLoS One\",\"uid\":\"25798947\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"8.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25.\",\"author\":\"Mustapha M\",\"pubdate\":\"2002 Apr\",\"source\":\"Hum Genet\",\"uid\":\"11941484\"},{\"title\":\"Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.\",\"author\":\"Weil D\",\"pubdate\":\"2003 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12588794\"},{\"title\":\"Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.\",\"author\":\"Riahi Z\",\"pubdate\":\"2015 Mar 23\",\"source\":\"PLoS One\",\"uid\":\"25798947\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.\",\"author\":\"Weil D\",\"pubdate\":\"2003 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12588794\"},{\"title\":\"Phosphorylation of the Usher syndrome 1G protein SANS controls Magi2-mediated endocytosis.\",\"author\":\"Bau\\u00df K\",\"pubdate\":\"2014 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24608321\"},{\"title\":\"SANS (USH1G) expression in developing and mature mammalian retina.\",\"author\":\"Overlack N\",\"pubdate\":\"2008 Feb\",\"source\":\"Vision Res\",\"uid\":\"17923142\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"6.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Heterozygous mutation of Ush1g\/Sans in mice causes early-onset progressive hearing loss, which is recovered by reconstituting the strain-specific mutation in Cdh23.\",\"author\":\"Miyasaka Y\",\"pubdate\":\"2016 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"26936824\"},{\"title\":\"Phosphorylation of the Usher syndrome 1G protein SANS controls Magi2-mediated endocytosis.\",\"author\":\"Bau\\u00df K\",\"pubdate\":\"2014 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24608321\"},{\"title\":\"Digenic inheritance of deafness caused by 8J allele of myosin-VIIA and mutations in other Usher I genes.\",\"author\":\"Zheng QY\",\"pubdate\":\"2012 Jun 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22381527\"},{\"title\":\"Usher type 1G protein sans is a critical component of the tip-link complex, a structure controlling actin polymerization in stereocilia.\",\"author\":\"Caberlotto E\",\"pubdate\":\"2011 Apr 5\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"21436032\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09\/21\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/15\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1487145600,
  "file":null,
  "dateISO8601":"2017-02-15T00:00:00",
  "entrez_id":"124590",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0010168"},
   "OMIM606943":
   {"ontology":"OMIM",
    "curie":"OMIM:606943",
    "uri":"OMIM606943",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_606943"},
   "ORPHA231169":
   {"ontology":"ORPHA",
    "curie":"ORPHA:231169",
    "uri":"ORPHA231169",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231169"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 15, 2017",
  "scoreJsonSerializedSop5":""},
 "6235":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"DNMT1 methylopathy",
  "genes":
  {"2976":{"ontology":"HGNC", "curie":"HGNC:2976", "uri":"HGNC2976"}},
  "title":"DNMT1 DNMT1 methylopathy",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"DNMT1\",\"Hgnc\":\"2976\",\"OrphaNet\":\" ORPHA314404\",\"Disease\":\"DNMT1 Methylopathy\",\"Omim\":\"604121\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"8.0\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.\",\"author\":\"Winkelmann J\",\"pubdate\":\"2012 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"22328086\"},{\"title\":\"Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy.\",\"author\":\"Kernohan KD\",\"pubdate\":\"2016 Sep 5\",\"source\":\"Clin Epigenetics\",\"uid\":\"27602171\"},{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"},{\"title\":\"Novel mutation in the replication focus targeting sequence domain of DNMT1 causes hereditary sensory and autonomic neuropathy IE.\",\"author\":\"Yuan J\",\"pubdate\":\"2013 Mar\",\"source\":\"J Peripher Nerv Syst\",\"uid\":\"23521649\"},{\"title\":\"DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2013 Feb 26\",\"source\":\"Neurology\",\"uid\":\"23365052\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.\",\"author\":\"Winkelmann J\",\"pubdate\":\"2012 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"22328086\"},{\"title\":\"A novel de novo exon 21 DNMT1 mutation causes cerebellar ataxia, deafness, and narcolepsy in a Brazilian patient.\",\"author\":\"Pedroso JL\",\"pubdate\":\"2013 Aug 1\",\"source\":\"Sleep\",\"uid\":\"23904686\"},{\"title\":\"Narcolepsy is a common phenotype in HSAN IE and ADCA-DN.\",\"author\":\"Moghadam KK\",\"pubdate\":\"2014 Jun\",\"source\":\"Brain\",\"uid\":\"24727570\"},{\"title\":\"Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.\",\"author\":\"Baets J\",\"pubdate\":\"2015 Apr\",\"source\":\"Brain\",\"uid\":\"25678562\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy.\",\"author\":\"Kernohan KD\",\"pubdate\":\"2016 Sep 5\",\"source\":\"Clin Epigenetics\",\"uid\":\"27602171\"},{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"},{\"title\":\"Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and autonomic neuropathy 1E.\",\"author\":\"Sun Z\",\"pubdate\":\"2014 Aug\",\"source\":\"Epigenetics\",\"uid\":\"25033457\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10\/14\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02\/10\/2017\",\"FinalClassificationNotes\":\"Clinical features of DNMT1 methylopathy include cerebellar ataxia, deafness, and narcolepsy. Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1486713600,
  "file":null,
  "dateISO8601":"2017-02-10T00:00:00",
  "entrez_id":"1786",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0011397"},
   "OMIM604121":
   {"ontology":"OMIM",
    "curie":"OMIM:604121",
    "uri":"OMIM604121",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_604121"},
   "ORPHA314404":
   {"ontology":"ORPHA",
    "curie":"ORPHA:314404",
    "uri":"ORPHA314404",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_314404"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Feb 10, 2017",
  "scoreJsonSerializedSop5":""},
 "8149":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Cone-rod dystrophy and hearing loss",
  "genes":
  {"25740":
   {"ontology":"HGNC", "curie":"HGNC:25740", "uri":"HGNC25740"}},
  "title":"CEP78 Cone-rod dystrophy and hearing loss",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"CEP78\",\"Hgnc\":\"25740\",\"OrphaNet\":\"\",\"Disease\":\"Cone-rod dystrophy and hearing loss\",\"Omim\":\"617236\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Novel Candidate Genes and a Wide Spectrum of Structural and Point Mutations Responsible for Inherited Retinal Dystrophies Revealed by Exome Sequencing.\",\"author\":\"de Castro-Mir\\u00f3 M\",\"pubdate\":\"2016\",\"source\":\"PLoS One\",\"uid\":\"28005958\"},{\"title\":\"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588451\"},{\"title\":\"Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss.\",\"author\":\"Namburi P\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588452\"},{\"title\":\"<i>CEP78<\/i> is mutated in a distinct type of Usher syndrome.\",\"author\":\"Fu Q\",\"pubdate\":\"2017 Mar\",\"source\":\"J Med Genet\",\"uid\":\"27627988\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"<i>CEP78<\/i> is mutated in a distinct type of Usher syndrome.\",\"author\":\"Fu Q\",\"pubdate\":\"2017 Mar\",\"source\":\"J Med Genet\",\"uid\":\"27627988\"},{\"title\":\"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588451\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588451\"},{\"title\":\"Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss.\",\"author\":\"Namburi P\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588452\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"11\",\"GeneticEvidencePointsTotal\":\"11\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"12.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"12\/27\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"04\/12\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1491980400,
  "file":null,
  "dateISO8601":"2017-04-12T00:00:00",
  "entrez_id":"84131",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0014980"},
   "OMIM617236":
   {"ontology":"OMIM",
    "curie":"OMIM:617236",
    "uri":"OMIM617236",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_617236"},
   "ORPHA":
   {"ontology":"ORPHA",
    "curie":"ORPHA:",
    "uri":"ORPHA",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_"}},
  "scores":{"3978":{"label":"Strong"}},
  "dateFormated":"Apr 12, 2017",
  "scoreJsonSerializedSop5":""},
 "5613":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":
  "Nonsyndromic sensorineural hearing loss (auditory neuropathy)",
  "genes":
  {"8515":{"ontology":"HGNC", "curie":"HGNC:8515", "uri":"HGNC8515"}},
  "title":
  "OTOF: Nonsyndromic sensorineural Hearing Loss (Auditory Neuropathy)",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"OTOF\",\"Hgnc\":\"8515\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural Hearing Loss (Auditory Neuropathy)\",\"Omim\":\"601071\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness.\",\"author\":\"Yasunaga S\",\"pubdate\":\"1999 Apr\",\"source\":\"Nat Genet\",\"uid\":\"10192385\"},{\"title\":\"A novel mutation in a family with non-syndromic sensorineural hearing loss that disrupts the newly characterised OTOF long isoforms.\",\"author\":\"Houseman MJ\",\"pubdate\":\"2001 Aug\",\"source\":\"J Med Genet\",\"uid\":\"11483641\"},{\"title\":\"Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness.\",\"author\":\"Mirghomizadeh F\",\"pubdate\":\"2002 Jul\",\"source\":\"Neurobiol Dis\",\"uid\":\"12127154\"},{\"title\":\"A novel otoferlin splice-site mutation in siblings with auditory neuropathy spectrum disorder.\",\"author\":\"Runge CL\",\"pubdate\":\"2013\",\"source\":\"Audiol Neurootol\",\"uid\":\"24135434\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"6.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"11.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness.\",\"author\":\"Yasunaga S\",\"pubdate\":\"1999 Apr\",\"source\":\"Nat Genet\",\"uid\":\"10192385\"},{\"title\":\"A novel mutation in a family with non-syndromic sensorineural hearing loss that disrupts the newly characterised OTOF long isoforms.\",\"author\":\"Houseman MJ\",\"pubdate\":\"2001 Aug\",\"source\":\"J Med Genet\",\"uid\":\"11483641\"},{\"title\":\"Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness.\",\"author\":\"Mirghomizadeh F\",\"pubdate\":\"2002 Jul\",\"source\":\"Neurobiol Dis\",\"uid\":\"12127154\"},{\"title\":\"A novel otoferlin splice-site mutation in siblings with auditory neuropathy spectrum disorder.\",\"author\":\"Runge CL\",\"pubdate\":\"2013\",\"source\":\"Audiol Neurootol\",\"uid\":\"24135434\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"TotalGeneticEvidencePoints\":{\"notes\":\"More genetic evidence is available, but the curator stopped at the max score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness.\",\"author\":\"Yasunaga S\",\"pubdate\":\"1999 Apr\",\"source\":\"Nat Genet\",\"uid\":\"10192385\"},{\"title\":\"Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse.\",\"author\":\"Roux I\",\"pubdate\":\"2006 Oct 20\",\"source\":\"Cell\",\"uid\":\"17055430\"},{\"title\":\"Otoferlin interacts with myosin VI: implications for maintenance of the basolateral synaptic structure of the inner hair cell.\",\"author\":\"Heidrych P\",\"pubdate\":\"2009 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"19417007\"}],\"notes\":{\"note\":\"Expression, Protein Interaction\"}}},\"ModelsRescue\":{\"value\":\"4.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse.\",\"author\":\"Roux I\",\"pubdate\":\"2006 Oct 20\",\"source\":\"Cell\",\"uid\":\"17055430\"}],\"notes\":{\"note\":\"Animal Model\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"17.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08\/25\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01\/30\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
  "date":1485763200,
  "file":null,
  "dateISO8601":"2017-01-30T00:00:00",
  "entrez_id":"9381",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0010986"},
   "OMIM601071":
   {"ontology":"OMIM",
    "curie":"OMIM:601071",
    "uri":"OMIM601071",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601071"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Jan 30, 2017",
  "scoreJsonSerializedSop5":""},
 "8701":
 {"affiliation":{"id":"10042", "name":"Breast\/Ovarian Cancer"},
  "label":"Familial ovarian cancer",
  "genes":
  {"HGNC:9948":
   {"ontology":"HGNC", "curie":"HGNC:9948", "uri":"HGNC9948"}},
  "title":"RECQL: Familial ovarian cancer",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"RECQL\",\"Hgnc\":\"9948\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N\/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"09\/14\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"09\/14\/2016\",\"FinalClassificationNotes\":\"\"}}",
  "date":1473836400,
  "file":null,
  "dateISO8601":"2016-09-14T00:00:00",
  "entrez_id":"5965",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0016248"},
   "OMIM":
   {"ontology":"OMIM",
    "curie":"OMIM:",
    "uri":"OMIM",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_"},
   "ORPHA213517":
   {"ontology":"ORPHA",
    "curie":"ORPHA:213517",
    "uri":"ORPHA213517",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213517"}},
  "scores":{"3975":{"label":"No Reported Evidence"}},
  "dateFormated":"Sep 14, 2016",
  "scoreJsonSerializedSop5":""},
 "8264":
 {"affiliation":
  {"id":"10044",
   "name":"Familial Thoracic Aortic Aneurysm and Dissection"},
  "label":"Familial thoracic aortic aneurysm and aortic dissection",
  "genes":
  {"HGNC:29673":
   {"ontology":"HGNC", "curie":"HGNC:29673", "uri":"HGNC29673"}},
  "title":
  "MFAP5 : Familial thoracic aortic aneurysm and aortic dissection",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"MFAP5\",\"Hgnc\":\"29673\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601103\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"c.62G>T (p.Trp21Leu) mutation segregating in a three generation family.  Points 1\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"c.472C>T (p.Arg158\\u2217) segregating  with disease in a large 3 generation family. Functional assays showed that c.472C>T leads to pure haploinsufficiency in heterozygous individuals.\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"Points inferred based on estimated LOD score from  combined  segregations from two families.\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25)\",\"author\":\"Gibson MA\",\"pubdate\":\"1996 Jan 12\",\"source\":\"J Biol Chem\",\"uid\":\"8557636\"},{\"title\":\"Microfibril-associated glycoprotein-2 specifically interacts with a range of bovine and human cell types via alphaVbeta3 integrin.\",\"author\":\"Gibson MA\",\"pubdate\":\"1999 May 7\",\"source\":\"J Biol Chem\",\"uid\":\"10224057\"},{\"title\":\"Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo.\",\"author\":\"Combs MD\",\"pubdate\":\"2013 Oct 4\",\"source\":\"J Biol Chem\",\"uid\":\"23963447\"},{\"title\":\"Microfibril-associated MAGP-2 stimulates elastic fiber assembly.\",\"author\":\"Lemaire R\",\"pubdate\":\"2007 Jan 5\",\"source\":\"J Biol Chem\",\"uid\":\"17099216\"},{\"title\":\"Pathway analysis of differentially expressed genes in patients with acute aortic dissection.\",\"author\":\"Mohamed SA\",\"pubdate\":\"2009 May 6\",\"source\":\"Biomark Insights\",\"uid\":\"19652764\"},{\"title\":\"Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.\",\"author\":\"Penner AS\",\"pubdate\":\"2002 Sep 20\",\"source\":\"J Biol Chem\",\"uid\":\"12122015\"}],\"notes\":{\"note\":\"Biochemical Function:\\r\\nPMIDs 8557636 and 10224057: Binding to extracellular matrix components (FBN1-containing microfibrils); adhesion of aortic smooth muscle and other vascular cells to extra cellular matrix (ECM) components and migration.\\r\\n\\r\\nPMID 17099216: Formation of elastin - containing elastic fibres. \\r\\nPMID 23963447: Binding to TGFB1 and TGFB2 - regulation of cell-cell signalling and TGFB pathway.\\r\\n\\r\\nProtein interaction:\\r\\nPMID: 8557636: adhesion to FBN1 - containing microfibrils\\r\\nPMID: 17099216: interaction with elastin\\r\\nPMID 23963447: interaction with TGFB1 and TGFB2 by binding\\r\\nPMID: 12122015: Binding to FBN1.\\r\\nExpression:\\r\\nPMID 19652764: downregulation of expression in aortic wall of patients with acute aortic dissection\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"Reduced expression of MFAP5 in patient cells; also reduced TGF-Beta signaling in patient tissue (increased TGFB1 and increased pSMAD2\/3)\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo.\",\"author\":\"Combs MD\",\"pubdate\":\"2013 Oct 4\",\"source\":\"J Biol Chem\",\"uid\":\"23963447\"}],\"notes\":{\"note\":\"Mouse model: MFAP5-\/- mice have no specific CV phenotype; double k\/o MFAP 2-\/-: MFAP5 -\/- mice have age-dependent aortic dilatation\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"07\/04\/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12\/22\/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
  "date":1482393600,
  "file":null,
  "dateISO8601":"2016-12-22T00:00:00",
  "entrez_id":"8076",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019625"},
   "OMIM601103":
   {"ontology":"OMIM",
    "curie":"OMIM:601103",
    "uri":"OMIM601103",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601103"},
   "ORPHA91387":
   {"ontology":"ORPHA",
    "curie":"ORPHA:91387",
    "uri":"ORPHA91387",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91387"}},
  "scores":{"3976":{"label":"Moderate"}},
  "dateFormated":"Dec 22, 2016",
  "scoreJsonSerializedSop5":""},
 "10153":
 {"affiliation":{"id":"10045", "name":"Brugada Syndrome"},
  "label":"Brugada Syndrome",
  "genes":
  {"HGNC:6241":
   {"ontology":"HGNC", "curie":"HGNC:6241", "uri":"HGNC6241"}},
  "title":"KCNE5: Brugada Syndrome",
  "type":"clinicalValidity",
  "scoreJsonSerialized":"",
  "date":1511251200,
  "file":null,
  "dateISO8601":"2017-11-21T00:00:00",
  "entrez_id":"23630",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0015263"},
   "OMIM601144":
   {"ontology":"OMIM",
    "curie":"OMIM:601144",
    "uri":"OMIM601144",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_601144"},
   "ORPHA130":
   {"ontology":"ORPHA",
    "curie":"ORPHA:130",
    "uri":"ORPHA130",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_130"}},
  "scores":{"3980":{"label":"Contradictory (disputed)"}},
  "dateFormated":"Nov 21, 2017",
  "scoreJsonSerializedSop5":
  "{\"iri\":\"http:\/\/www.clinicalgenome.org\/gci-lite\/1530659024\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNE5\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6241\",\"uri\":\"HGNC6241\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNE5 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.40\",\"Tally\":\"0.4\",\"evidence\":{\"publications\":{\"1530659138901\":{\"title\":\"KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation.\",\"author\":\"Ohno S\",\"pubdate\":\"2011 Jun\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"21493962\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.4\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530659173839\":{\"title\":\"KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.\",\"author\":\"Abbott GW\",\"pubdate\":\"2016 Nov 30\",\"source\":\"Gene\",\"uid\":\"27484720\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.25\",\"ProteinInteraction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530659276757\":{\"title\":\"KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.\",\"author\":\"Abbott GW\",\"pubdate\":\"2016 Nov 30\",\"source\":\"Gene\",\"uid\":\"27484720\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530659282381\":{\"title\":\"KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.\",\"author\":\"Abbott GW\",\"pubdate\":\"2016 Nov 30\",\"source\":\"Gene\",\"uid\":\"27484720\"},\"1530659349056\":{\"title\":\"KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs.\",\"author\":\"Piccini M\",\"pubdate\":\"1999 Sep 15\",\"source\":\"Genomics\",\"uid\":\"10493825\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.4\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"1.65\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01\/07\/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11\/21\/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}"},
 "8406":
 {"affiliation":{"id":"10007", "name":"Hearing Loss"},
  "label":"Nonsyndromic sensorineural hearing loss",
  "genes":
  {"26257":
   {"ontology":"HGNC", "curie":"HGNC:26257", "uri":"HGNC26257"}},
  "title":"PDZD7: Nonsyndromic sensorineural hearing loss",
  "type":"clinicalValidity",
  "scoreJsonSerialized":
  "{\"data\":{\"Gene\":\"PDZD7\",\"Hgnc\":\"26257\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"612971\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"8.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment.\",\"author\":\"Schneider E\",\"pubdate\":\"2009 Feb 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"19028668\"},{\"title\":\"PDZD7 and hearing loss: More than just a modifier.\",\"author\":\"Booth KT\",\"pubdate\":\"2015 Dec\",\"source\":\"Am J Med Genet A\",\"uid\":\"26416264\"},{\"title\":\"Confirmation of PDZD7 as a Nonsyndromic Hearing Loss Gene.\",\"author\":\"Vona B\",\"pubdate\":\"2016 Jul-Aug\",\"source\":\"Ear Hear\",\"uid\":\"26849169\"},{\"title\":\"DNA Diagnostics of Hereditary Hearing Loss: A Targeted Resequencing Approach Combined with a Mutation Classification System.\",\"author\":\"Sommen M\",\"pubdate\":\"2016 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"27068579\"},{\"title\":\"Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran.\",\"author\":\"Sloan-Heggen CM\",\"pubdate\":\"2015 Dec\",\"source\":\"J Med Genet\",\"uid\":\"26445815\"},{\"title\":\"An example of the utility of genomic analysis for fast and accurate clinical diagnosis of complex rare phenotypes.\",\"author\":\"Le Quesne Stabej P\",\"pubdate\":\"2017 Feb 7\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"28173822\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"2.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"11.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"PDZD7 and hearing loss: More than just a modifier.\",\"author\":\"Booth KT\",\"pubdate\":\"2015 Dec\",\"source\":\"Am J Med Genet A\",\"uid\":\"26416264\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"PDZD7-MYO7A complex identified in enriched stereocilia membranes.\",\"author\":\"Morgan CP\",\"pubdate\":\"2016 Aug 15\",\"source\":\"Elife\",\"uid\":\"27525485\"},{\"title\":\"Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice.\",\"author\":\"Zou J\",\"pubdate\":\"2014 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24334608\"},{\"title\":\"Characterization of transcriptomes of cochlear inner and outer hair cells.\",\"author\":\"Liu H\",\"pubdate\":\"2014 Aug 13\",\"source\":\"J Neurosci\",\"uid\":\"25122905\"},{\"title\":\"Localization of PDZD7 to the stereocilia ankle-link associates this scaffolding protein with the Usher syndrome protein network.\",\"author\":\"Grati M\",\"pubdate\":\"2012 Oct 10\",\"source\":\"J Neurosci\",\"uid\":\"23055499\"},{\"title\":\"Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment.\",\"author\":\"Schneider E\",\"pubdate\":\"2009 Feb 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"19028668\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice.\",\"author\":\"Zou J\",\"pubdate\":\"2014 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24334608\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"11\/25\/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"04\/26\/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hereditary Hearing Loss Working Group\"}}",
  "date":1493190000,
  "file":null,
  "dateISO8601":"2017-04-26T00:00:00",
  "entrez_id":"79955",
  "conditions":
  {"MONDO":
   {"ontology":"MONDO",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/MONDO_0019588"},
   "OMIM612971":
   {"ontology":"OMIM",
    "curie":"OMIM:612971",
    "uri":"OMIM612971",
    "iri":"http:\/\/purl.obolibrary.org\/obo\/OMIM_612971"},
   "ORPHA90636":
   {"ontology":"ORPHA",
    "curie":"ORPHA:90636",
    "uri":"ORPHA90636",
    "iri":"http:\/\/www.orpha.net\/ORDO\/Orphanet_90636"}},
  "scores":{"3979":{"label":"Definitive"}},
  "dateFormated":"Apr 26, 2017",
  "scoreJsonSerializedSop5":""}}
